Method and system for evaluating flow cytometer data for presence of coincidence events

By evaluating the particle time interval in the flow cytometer and processing the corresponding data, the crosstalk problem between the laser and the detector is solved, and the accuracy and fidelity of the data are improved. It is suitable for flow cytometers under multi-color conditions operate.

CN119072620APending Publication Date: 2024-12-03BECTON DICKINSON & CO
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
CN202380035670.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-24
Filing Date
2023-01-10
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The crosstalk problem between lasers and detectors in existing flow cytometry systems leads to reduced data fidelity and confusing artifacts, especially in the multi-color growth trend, affecting the accuracy of the data.

Method used

By receiving flow cytometry data associated with the first and second particles, generating their time intervals, and evaluating the presence of overlapping events based on this interval, and modifying or ignoring data that may be affected by crosstalk, using multiple light sources and detector to reduce crosstalk occurrence.

Benefits of technology

Improves the quality of flow cytometry data, recognizes and mitigates the impact of crosstalk, and enhances the fidelity and accuracy of the data, especially in multi-color conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119072620A_ABST
    Figure CN119072620A_ABST
Patent Text Reader

Abstract

Methods of evaluating flow cytometer data for the presence of coincidence events are provided. A target method includes receiving flow cytometer data associated with a first particle, wherein the received flow cytometer data is obtained from a detector after the first and second particles in a flow stream are illuminated by a first light source and a second light source, respectively. The method further includes receiving a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. Further, the method of the invention comprises generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and generating the first particle and the second particle based on the generated time interval by determining whether the first particle and the second particle are simultaneously illuminated by the first light source and the second light source. Flow cytometer data is evaluated for the presence of coincidence events. Systems and computer readable media are also provided.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to related patent applications

[0002] This application claims priority under 35 U.S.C. 119(e) to the filing date of U.S. Provisional Patent Application Serial No. 63 / 313,391, filed on February 24, 2022, the disclosure of which is incorporated herein by reference in its entirety. Background Art

[0003] Characterization of analytes in biological fluids has become an essential component of biological research, medical diagnostics, and assessing a patient's overall health and wellness. Testing for analytes in biological fluids, such as human blood or blood derivatives, provides results that may play a role in determining treatment options for patients with a variety of diseases.

[0004] Flow cytometry is a technique used to characterize and often classify biological material, such as cells of a blood sample or target particles in another biological or chemical sample. A flow cytometer typically includes a sample container for receiving a liquid sample (such as a blood sample) and a sheath container containing a sheath fluid. A flow cytometer delivers particles (including cells) in a liquid sample as a stream of cells to a flow cell, while also directing a sheath fluid to the flow cell. To characterize the composition of the flowing stream, the flowing stream is illuminated with light. Changes in the material in the flowing stream, such as morphology or the presence of fluorescent markers, can result in changes in the light observed, and these changes allow for characterization and separation. To characterize the composition of the flowing stream, light must be incident on the stream and collected. The light source in a flow cytometer can vary and can include one or more broad spectrum lamps, light emitting diodes, and single wavelength lasers. The light source is aligned with the flowing stream and collects and quantifies the optical response from the illuminated particles.

[0005] In a spatially separated multi-laser flow cytometer system, there are apertures that are arranged to collect fluorescent emissions from cells as they pass through each laser beam in the system. The emissions collected through these apertures are typically directed to separate detector arrays, one for each laser beam. Because the laser beams are spatially separated from each other, and the apertures nominally block fluorescence emitted by cells passing through non-primary lasers, it is generally assumed that any crosstalk between the lasers and detectors is present within acceptable levels. Current systems do not address the crosstalk problem and rely on the relatively low frequency at which crosstalk occurs and the typically low amplitude when crosstalk occurs. Summary of the invention

[0006] The inventors of the present application have recognized that even if the possibility of crosstalk between lasers and detectors was previously an acceptable defect, the growing trend to include more colors in flow cytometry protocols is stressing the system, and the noise generated by such crosstalk can reduce the fidelity of the data and potentially produce aliasing artifacts. Furthermore, as flow cytometers evolve and speed requirements increase, the occurrence of such coincidences becomes more likely. Therefore, it is desirable to at least identify situations where data may be suspected of crosstalk. Embodiments of the present invention meet this desire.

[0007] Aspects of the present invention include methods for evaluating flow cytometer data for the presence of a coincident event. The target method includes receiving flow cytometer data associated with a first particle, wherein the flow cytometer data is obtained from a detector after the first particle and the second particle in the flow stream are illuminated by a first light source and a second light source, respectively. The method also involves receiving a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. The method also includes generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and based on the generated time interval, by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time, evaluating the flow cytometer data for the presence of a coincident event. In an embodiment, the first trigger signal and the second trigger signal respectively represent the time points at which the first particle and the second particle are detected in the flow stream, and can be used to estimate the relative positions of the first particle and the second particle in the flow stream. In some embodiments, evaluating the flow cytometer data includes comparing the generated time interval with a measurement window associated with the second light source, for example, the measurement window defines the time period during which the illumination of the second particle produces a coincident event. In some such embodiments, evaluating the flow cytometer data may include determining whether the second particle falls within a measurement window of the second light source based on the time interval while acquiring the flow cytometer data associated with the first particle from the detector. In other cases, evaluating the flow cytometer data includes comparing the time interval with a standard value, such as determining whether the time interval is below the standard value.

[0008] After evaluating the flow cytometer data, the method may include modifying the flow cytometer data generated by the coincident event. For example, in some embodiments, the method includes assigning a coincidence identifier to the flow cytometer data containing the coincident event. In other cases, the method includes ignoring the flow cytometer data containing the coincident event. In some cases, the method is repeated for different pairs of first particles and second particles. In other words, the method includes evaluating the flow cytometer data associated with multiple different pairs of first particles and second particles from the particle sample. In some cases, the first particles and the second particles are continuous particles in the flow stream. In other cases, the first particles and the second particles are non-continuous particles in the flow stream.

[0009] The flow cytometer data evaluated in the present method can be received from a previously conducted experiment (i.e., received from storage / memory) or received in real time from a flow cytometer experiment. When the flow cytometer data is received in real time, the method may also include irradiating the first particle and the second particle in the flow stream with a first light source and a second light source, respectively. If and when a coincidence event is detected regarding the first particle and the second particle, an embodiment of the present method includes deactivating the second light source during the coincidence event. In some cases, the first light source and the second light source are selected from a plurality of light sources (e.g., 2 to 10 different light sources). The plurality of light sources may include, for example, one or more lasers. Similarly, in some cases, the detector is selected from a plurality of detectors (e.g., 2 to 10 different detectors). The plurality of detectors may include, for example, one or more detector arrays.

[0010] Aspects of the present invention also include systems. The target system includes: a flow cell configured to transport a particle sample in a flow body; a first light source and a second light source configured to illuminate a first particle and a second particle in the particle sample, respectively; a detector configured to generate flow cytometer data associated with the first particle; and a processor. The processor of the subject matter is configured to execute the method of the subject matter (e.g., as described above) and receive flow cytometer data associated with the illuminated first particle and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively, from the detector. In addition, the processor is configured to generate a time interval for the first particle and the second particle based on the difference between the first trigger signal and the second trigger signal, and based on the time interval, by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time, evaluate the obtained flow cytometer data for the presence of a coincidence event. In some cases, the system includes a plurality of light sources (e.g., 2 to 10 different light sources), and the first light source and the second light source are selected from the plurality of light sources. The plurality of light sources may include, for example, one or more lasers. In other cases, the system includes a plurality of detectors (e.g., 2 to 10 different detectors), and the detector is selected from a plurality of detectors. In some cases, the system is a flow cytometer. In some embodiments, the system may further include a display configured to output the flow cytometer data evaluated by the processor.

[0011] Aspects of the present invention also include a non-transitory computer-readable storage medium including instructions stored thereon for evaluating flow cytometer data for the presence of coincident events using the method of the present invention. Specifically, the non-transitory computer-readable storage medium of the present subject matter includes instructions for receiving flow cytometer data associated with a first particle, and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively, wherein the flow cytometer data is obtained from a detector after the first particle and the second particle in the flow stream are illuminated by a first light source and a second light source, respectively. The target non-transitory computer-readable storage medium also includes instructions for generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and instructions for evaluating the flow cytometer data for the presence of coincident events by determining whether the first particle and the second particle are illuminated by the first and second light sources at the same time based on the generated time interval. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] The present invention may be best understood when the following detailed description is read in conjunction with the accompanying drawings, which include the following figures:

[0013] Figure 1A -B Flow cytometry scenarios involving crosstalk ( Figure 1B ) and flow cytometry scenarios without crosstalk ( Figure 1A ) were compared.

[0014] Figure 2 A flow chart is presented for evaluating flow cytometer data for the presence of coincident events according to certain embodiments.

[0015] Figure 3 A functional block diagram of a flow cytometry system according to certain embodiments is shown.

[0016] Figure 4 A control system according to certain embodiments is shown.

[0017] Figure 5A -B shows a schematic diagram of a particle sorter system according to certain embodiments.

[0018] Figure 6 A block diagram of a computing system is shown in accordance with some embodiments. DETAILED DESCRIPTION

[0019] A method for evaluating flow cytometer data for the presence of coincident events is provided. The target method includes receiving flow cytometer data associated with a first particle, wherein the flow cytometer data is obtained from a detector after the first particle and the second particle in the flow stream are illuminated by a first light source and a second light source, respectively. The method also includes receiving a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. In addition, the method of the subject matter also includes generating a time interval between the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and based on the generated time interval, by determining whether the first particle and the second particle are illuminated by the first and second light sources at the same time, evaluating the flow cytometer data for the presence of coincident events. Systems and computer-readable media are also provided.

[0020] Before describing the present invention in more detail, it should be understood that the present invention is not limited to the specific embodiments described, because these embodiments can certainly vary. It should also be understood that the terms used herein are only used for the purpose of describing specific embodiments and are not intended to be limiting, because the scope of the present invention is limited only by the appended claims.

[0021] When providing a numerical range, it should be understood that unless the context clearly specifies otherwise, each intermediate value between the upper and lower limits of the range (accurate to one tenth of the lower limit unit) and any other described or intermediate values ​​in the described range are included in the present invention. The upper and lower limits of these smaller ranges can be independently included in the smaller range, and are also included in the present invention, but are affected by any specific exclusive limits in the described range. When the described range includes one or two limits, the scope excluding one or two of the included restrictions is also included in the present invention.

[0022] Certain ranges of values ​​given herein are preceded by the term "about." As used herein, the term "about" provides literal support for the exact number preceding it, as well as numbers that are close to or approximately preceding the term. In determining whether a number is close to or approximately a specifically recited number, a close or approximate unrecited number may be a number that, in the context in which it is presented, provides a substantial equivalence to the specifically recited number.

[0023] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used to practice or test the present invention, representative illustrative methods and materials are now described.

[0024] All publications and patents cited in this specification are incorporated herein by reference as if each individual publication or patent was specifically and individually indicated to be incorporated herein by reference, and are incorporated herein by reference to disclose and describe the methods and / or materials associated with the cited publications. Citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. In addition, the publication dates provided may be different from the actual publication dates and may need to be independently confirmed.

[0025] It is noted that, as used in the present disclosure and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. It should also be noted that the claims may be drafted to exclude any optional elements. Therefore, this statement is intended to serve as a precondition for using exclusive terminology such as "only," "only" and the like in connection with the recitation of claim elements or using a "negative" limitation.

[0026] After reading this disclosure, it will be apparent to those skilled in the art that each individual embodiment described and illustrated herein has separate components and features that can be easily separated or combined with the features of any of the other several embodiments without departing from the scope or spirit of the invention. Any narrated method can be performed in the order of narrated events or in any other order that is logically possible.

[0027] Although the systems and methods have been or will be described for the sake of grammatical fluency and functional explanation, it should be expressly understood that unless expressly formulated pursuant to 35 U.S.C. § 112, the claims shall not be construed as necessarily being limited in any manner to “means” or “steps” but shall be given the full meaning and scope of equivalents provided by the claims in accordance with the doctrine of judicial equivalents, and if the claims are expressly formulated pursuant to 35 U.S.C. § 112, they shall be given their full statutory equivalents pursuant to 35 U.S.C. § 112.

[0028] Methods for evaluating flow cytometry data

[0029] As described above, aspects of the present invention include a method for evaluating flow cytometer data for the presence of coincident events. As described herein, a "coincidence event" refers to flow cytometer bio-event data obtained from a flow cytometer protocol, wherein a detector collects light from a first particle illuminated by a first light source while a second particle is illuminated by a second light source. In other words, if a first particle and a second particle are illuminated by a first light source and a second light source at the same time, there is a coincidence event in the flow cytometer data. As described in the Summary of the Invention section, light emitted by a cell traveling through a non-master laser may be collected by a detector associated with a master laser. This can result in "crosstalk" that may damage the data. The "master" and "non-master" designations can refer to the correspondence between a given light source and the particles it illuminates. In the case where a particle passes through a beam emitted by a first light source when a second light source is active, the first light source is designated as the master light source relative to the particle, and the second light source is the non-master light source relative to the same particle. In some cases, evaluating flow cytometer data for the presence of coincidence events improves the quality of the flow cytometer data, for example, by allowing identification and / or removal of potentially suspicious flow cytometer data that may contain artifacts.

[0030] The target method includes receiving flow cytometer data associated with a first particle. The flow cytometer data is obtained from a detector after the first particle and the second particle in the flow stream are irradiated by the first light source and the second light source, respectively. The detector of the present subject matter can be any convenient detector, which is configured to collect light from the irradiated particles in the flow stream. The target detector can include, but is not limited to, an optical sensor or detector, such as an active pixel sensor (APS), an avalanche photodiode (APD), an image sensor, a charge coupled device (CCD), an enhanced charge coupled device (ICCD), a light emitting diode, a photon counter, a bolometer, a pyroelectric detector, a photoresistor, a photovoltaic cell, a photodiode, a photomultiplier tube (PMT), a phototransistor, a quantum dot photoconductor or a photodiode and a combination thereof, and other detectors. In certain embodiments, the collected light is measured using a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In some embodiments, the detector is selected from a plurality of detectors. In other words, a given flow cytometer receiving the flow cytometer data of the present subject can include multiple detectors, and the target detector of the method of the present subject can be selected from any one of these detectors. The number of detectors in the multiple detectors can be, for example, 2 to 20 (e.g., 2 to 10). In some cases, the detector in the multiple detectors is a fluorescence detector. Each detector in the multiple detectors can be of any suitable type, including but not limited to those listed above.

[0031] In some embodiments, the plurality of detectors include one or more detector arrays, such as photodiode arrays. In these embodiments, each detector array may include 4 or more detectors, such as 10 or more detectors, such as 25 or more detectors, such as 50 or more detectors, such as 100 or more detectors, such as 250 or more detectors, such as 500 or more detectors, such as 750 or more detectors, and including 1000 or more detectors. For example, the detector may be a photodiode array having 4 or more photodiodes, such as 10 or more photodiodes, such as 25 or more photodiodes, such as 50 or more photodiodes, such as 100 or more photodiodes, such as 250 or more photodiodes, such as 500 or more photodiodes, such as 750 or more photodiodes, and including 1000 or more photodiodes.

[0032] The detectors may be arranged in any geometric configuration as desired, wherein target arrangements include, but are not limited to, square configurations, rectangular configurations, trapezoidal configurations, triangular configurations, hexagonal configurations, heptagonal configurations, octagonal configurations, nonagonal configurations, decagonal configurations, dodecagonal configurations, circular configurations, elliptical configurations, and irregular pattern configurations. The detectors in the detector array may be oriented at angles relative to each other (with reference to the XZ plane) in the range of 10° to 180°, such as 15° to 170°, such as 20° to 160°, such as 25° to 150°, such as 30° to 120°, including 45° to 90°. The detector array may be of any suitable shape, and may be a rectilinear shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., or a curved shape, such as a circle, an ellipse, or an irregular shape, such as a parabolic bottom coupled to a planar top. In some embodiments, the detector array has a rectangular effective surface.

[0033] In addition, the first light source and the second light source for irradiating the first particle and the second particle can independently be any convenient light source configured to irradiate the particles in the flow stream. For example, in some embodiments, one or more of the first light source and the second light source is a laser. In an embodiment, the laser can be any convenient laser, such as a continuous wave laser. For example, the laser can be a diode laser, such as an ultraviolet diode laser, a visible diode laser, and a near-infrared diode laser. In other embodiments, the laser can be a helium-neon (HeNe) laser. In some cases, the laser is a gas laser, such as a helium-neon laser, an argon laser, a krypton laser, a xenon laser, a nitrogen laser, a CO2 laser, a CO laser, an argon-fluorine (ArF) excimer laser, a krypton-fluorine (KrF) excimer laser, a xenon-chlorine (XeCl) excimer laser, or a xenon-fluorine (XeF) excimer laser or a combination thereof. In other cases, the flow cytometer of the present subject includes a dye laser, such as a stilbene, a coumarin, or a rhodamine laser. In some cases, the target laser includes a metal vapor laser, such as a helium cadmium (HeCd) laser, a helium mercury (HeHg) laser, a helium selenium (HeSe) laser, a helium silver (HeAg) laser, a strontium laser, a neon copper (NeCu) laser, a copper laser or a gold laser and a combination thereof. In other cases, the flow cytometer of the present subject includes a solid-state laser, such as a ruby ​​laser, a Nd:YAG laser, a NdCrYAG laser, an Er:YAG laser, a Nd:YLF laser, a Nd:YVO4 laser, a Nd:YCa4O(BO3)3 laser, a Nd:YCOB laser, a titanium sapphire laser, a thulium YAG laser, a ytterbium YAG laser, a ytterbium 2O3 laser or a cerium-doped laser and a combination thereof. In some cases, the first light source and the second light source are selected from a plurality of light sources. In other words, a given flow cytometer receiving the flow cytometer data of the present subject matter may include a plurality of light sources, and the first light source and the second light source targeted by the method of the present subject matter may be selected from any two of these light sources. The number of light sources in the plurality of light sources may range from, for example, 2 to 20, such as 2 to 10. The light sources (e.g., lasers) in the plurality of light sources may be of any convenient type, including but not limited to the types described above.

[0034] Aspects of the present invention also include receiving a first trigger signal and a second trigger signal associated with a first particle and a second particle, respectively. A "trigger signal" refers to the time point at which a given particle is first detected in a flow stream. Therefore, in some cases, the first trigger signal and the second trigger signal indicate the time point at which the first particle and the second particle are detected in the flow stream, respectively. The trigger signal of the present subject matter can be received from any suitable detector in a flow cytometer. For example, in some cases, a trigger signal is received from a forward scattered light detector. In other embodiments, a trigger signal is received from a side scattered light detector. In yet other embodiments, a trigger signal is received from an axial light loss (ALL) detector. In other embodiments, a trigger signal is received from a fluorescence detector. Embodiments of the present invention include receiving a trigger signal for each particle in a flow stream. In some embodiments, each trigger signal can be used to provide an approximation of the position of a particle at any point in the flow stream during its transmission. In these embodiments, the position of the particle can be approximately calculated using the trigger signal and the flow velocity of the flow stream.

[0035] After receiving the flow cytometer data and the first trigger signal and the second trigger signal, aspects of the method include generating a time interval for the first particle and the second particle based on the difference between the first trigger signal and the second trigger signal. For example, where t1 is the time point associated with the first trigger signal and t2 is the time point associated with the second trigger signal, the time interval can be calculated by finding |t2-t1|. In some cases, the time interval represents the amount of time that has passed between the time point at which the first particle is detected in the flow stream (i.e., the first trigger signal) and the time point at which the second particle is detected in the flow stream (i.e., the second trigger signal). In some cases, the generated time interval provides an approximation of the relative position of the first particle and the second particle in the flow stream. In other words, assuming a constant flow rate, the generated time interval will correspond to a specific (e.g., constant) distance measured relative to the flow axis separating the first particle and the second particle when the particles are transported.

[0036] After generating the time interval, the target method also includes evaluating the flow cytometer data for the presence of a coincidence event based on the generated time interval. In other words, the method includes determining whether the first particle and the second particle are simultaneously irradiated by the first light source and the second light source. Any convenient method can be applied to determine the presence of a coincidence event. In some cases, evaluating the flow cytometer data includes comparing the time interval with the measurement window associated with the second light source. "Measurement window" refers to the time period during which the second light source irradiates the second particle to produce a coincidence event. In other words, based on the time interval generated during the first light source irradiating the first particle, the second particle estimated to be located in the interrogation zone of the second light source is referred to as being located in the measurement window associated with the second light source. As described herein, "interrogation zone" refers to the area in the flow stream where the particles are irradiated by light from the light source, such as for analysis. The size of the interrogation zone can be varied as needed. For example, when 0 μm represents the optical axis emitted by the light-related light source, the range of the interrogation zone can be -100 μm to 100 μm, such as -50 μm to 50 μm, such as -25 μm to 40 μm, and includes -15 μm to 30 μm. Thus, according to these embodiments, evaluating the flow cytometer data includes determining whether the second particle falls within the measurement window of the second light source based on the time interval while obtaining the flow cytometer data associated with the first particle from the detector. Since the time interval is related to the distance between the first particle and the second particle when traveling in the flow stream (i.e., as described above), it is possible to determine whether the first particle and the second particle separated by such a distance will exist simultaneously in the interrogation zone of the first light source and the second light source at a certain moment when they travel in the flow stream, i.e., in contrast to particles associated with a larger or smaller time interval that cannot exist simultaneously in the interrogation zone of the first light source and the second light source. In some embodiments, the method includes determining whether the generated time interval exists within a time value range associated with the measurement window. If the time interval exists within the time value range associated with the measurement window, it can be determined that the resulting flow cytometer data includes a coincidence event. If the time interval is not within the time value range associated with the measurement window (i.e., it is above or below the range), it can be determined that the resulting flow cytometer data does not include a coincidence event.

[0037] In other cases, evaluating the flow cytometer data includes comparing the time interval with a standard value. As described above, only particles that are separated by a certain distance in the flow stream may be irradiated by the first light source and the second light source at the same time. Therefore, a method for identifying coincidence events is to regard particles with a separation distance (i.e., determined by the time interval) that is less than the standard value as likely to cause crosstalk. In other words, in these embodiments, evaluating the flow cytometer data includes determining whether the time interval is lower than the standard value. In some cases, the standard value is a time length. If the time interval is lower than the time length associated with the standard value, it can be determined that the resulting flow cytometer data is related to the coincidence event. In some embodiments, when it is desired to be more conservative in evaluating the flow cytometer data for coincidence events, the standard value of the present subject is adopted, that is, by specifying the flow cytometer data that may involve synchronization as including coincidence events.

[0038] In addition, embodiments of the method include evaluating flow cytometer data associated with multiple different pairs of first and second particles from a particle sample. In other words, the method is repeated so that different particles are designated as first and second particles. In some embodiments, a particle that was once a first particle in an earlier iteration of the method may be subsequently considered a second particle, and so on. In some cases, the method is repeated so that each particle analyzed in the particle sample is designated as a first particle and / or a second particle at least once. Detectors and first and second light sources may be the same or different in the iteration of the method. For example, different light source groups in a plurality of light sources may be designated as the target first light source and target second light source of the method in a separate iteration. Similarly, different detectors in a plurality of detectors may be designated as the target detector of the method in a separate iteration. In certain cases where the flow cytometer data associated with a given group of first and second particles determined for a specific light source and detector combination include coincidence events, it can be inferred that the flow cytometer data received by one or more other detectors from the specific first particle (i.e., when the particle advances in the flow stream) also includes coincidence events. Assuming that the flow rate is constant, it can be assumed that the distance separating the first particle and the second particle remains constant when the particles pass through the flow cell. Therefore, the first particle and the second particle associated with the time interval (e.g., a time interval that has been found to be within the measurement window or below a standard value) may continue to generate flow cytometer data with coincident events when they are measured by other light sources and detectors. Therefore, the flow cytometer data measured from the particle at each detector may similarly include coincident events. The first particle and the second particle may or may not be continuous particles in the flow stream. In some cases, the first particle and the second particle are continuous particles in the flow stream (i.e., there are no particles separating them). In other cases, the first particle and the second particle are discontinuous particles in the flow stream (i.e., there are one or more particles separating them).

[0039] Figure 1A -B will not involve crosstalk in flow cytometry scenarios ( Figure 1A ) and flow cytometry scenarios involving crosstalk ( Figure 1B ) are compared. Particle 102 flows through flow cell 101 along direction d. Figure 1A In the scenario of FIG. 1 , five different lasers 103a-e illuminate the flow stream at interrogation zones 104a-e, respectively. A first particle is illuminated by laser 103a in interrogation zone 104a. The particle modulated light generated by the particle illumination is collected by detector 105. However, there is no second particle in the illumination zone of any other light source (i.e., 103b-e). Therefore, Figure 1A Particles illuminated in the flow cytometer are not associated with crosstalk or flow cytometric data with coincident events. Figure 1B A scenario that may lead to a coincidence event is shown in Figure 1. Figure 1B As shown, a first particle is illuminated by laser 103a in interrogation zone 104a, while a second particle is illuminated by laser 103b in interrogation zone 104b. Particle modulated light resulting from illumination of particles in illumination zone 104a is collected by detector 105, while particle modulated light resulting from illumination of particles in interrogation zone 104b is collected by detector 106. However, crosstalk between the lasers can be observed. As shown in region 107, the light detected by each of detectors 105 and 106 overlaps slightly. In other words, part of the light from interrogation zone 104b is collected by detector 105, and part of the light from interrogation zone 104a is collected by detector 106. Therefore, the flow cytometer data collected by detectors 106 and 107 in this scenario includes coincident events. The present invention anticipates this situation by generating time intervals for the first particle and the second particle. It is also worth noting that once the first particle and the second particle advance through the flow cell in direction d, the first particle and the second particle are spaced apart so that they will also be irradiated by lasers 103b and 103c simultaneously, by lasers 103c and 103d simultaneously, and by lasers 103d and 103e simultaneously. Therefore, the particle modulated light received by the detector associated with these light sources (not shown) may also result in a coincidence event. Therefore, embodiments of the present method also relate to predicting that two particles with a specific time interval will result in a coincidence event at multiple locations.

[0040] When the flow cytometer data being evaluated includes a coincidence event (i.e., as described above), embodiments of the present method may also include modifying the flow cytometer data being evaluated. In some cases, modifying the flow cytometer data being evaluated (when performed) includes ignoring the flow cytometer data containing the coincidence event. "Ignoring" the flow cytometer data means deleting the affected flow cytometer data from the remaining data collected by the experiment. In other embodiments, the method includes assigning a coincidence identifier to the flow cytometer data containing the coincidence event. In other words, the affected flow cytometer data is marked as potentially compromised. Any convenient coincidence identifier may be used. For example, when the flow cytometer data is displayed to the user, the affected flow cytometer may be displayed in a certain color to indicate to the user that the data contains a coincidence event. In other cases, the method includes providing a user with a notification of the presence and location of the affected data. The individual interpreting the flow cytometer data may then make an informed assessment of the impact of these data on the overall quality of the data.

[0041] In some embodiments, the method includes deactivating the second light source during the coincidence event. In other words, the method includes predicting when a coincidence event may occur and deactivating the second (i.e., non-primary) light source accordingly to prevent the flow cytometer data from being affected. The method may also include reactivating the second light source after the time period during which the coincidence may occur has passed.

[0042] Figure 2 A flow chart for evaluating flow cytometer data for the presence of coincident events according to certain embodiments is shown. Step 201 includes receiving flow cytometer data associated with a first particle and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. Step 202 includes generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal. Step 203 includes evaluating the flow cytometer data for the presence of coincident events by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time based on the generated time interval. In step 204, it is determined whether there is a coincident event in the flow cytometer data evaluated in step 203. If the evaluated flow cytometer data includes a coincident event, step 205 includes modifying the evaluated flow cytometer data (e.g., by ignoring it or assigning a coincidence identifier to it). Subsequently, the method is repeated for different pairs of the first particle and the second particle in step 206. If the evaluated flow cytometer data does not include a coincident event, the method proceeds directly to step 206 without modifying the evaluated flow cytometer data.

[0043] The flow cytometer data evaluated in the present method can be received from a previously performed experiment (e.g., from storage / memory), or can be received in real time from a flow cytometer experiment. In other words, after the first particle and the second particle in the flow stream are irradiated by the first light source and the second light source, the time period for obtaining the flow cytometer data from the detector can exist in the past, or can be a part of an ongoing experiment. When the flow cytometer data is received from a previously performed experiment, the time period for obtaining the flow cytometer data can range from, for example, the past 1 second or more seconds to the past 25 years or more years. For example, the time period for obtaining the flow cytometer data can be the past 1 second or more, the past 5 seconds or more, the past 10 seconds or more, the past 1 minute or more, the past 5 minutes or more, the past 10 minutes or more, the past 30 minutes or more, the past 1 hour or more, the past 5 hours or more, the past 10 hours or more, the past 1 day or more, the past 3 days or more, the past 1 week or more, the past 3 weeks or more, the past 1 month or more, the past 3 months or more, the past 6 months or more, the past 1 year or more, the past 3 years or more, the past 6 years or more, the past 15 years or more, the past 20 years or more or the past 25 years or more. In some embodiments, flow cytometry data received from previously performed experiments are stored in a storage device. Flow cytometry data from previously performed experiments can be stored in a memory, which can be any of a variety of known or future memory storage devices. Examples include any available random access memory (RAM), magnetic media (e.g., resident hard disk or tape), optical media (e.g., read-write optical disk), flash memory device, cloud storage device, or other memory storage device.

[0044] When an embodiment of the method includes receiving flow cytometer data from an experiment in real time, aspects of the present invention also include irradiating the first particle and the second particle in the flow cytometer with the first light source and the second light source, respectively. When implementing the method of this theme, a sample having at least the first particle and the second particle is irradiated with light from at least the first light source and the second light source (e.g., in the flow stream of the flow cytometer). In some embodiments, at least one light source is a broadband light source, emitting light with a wide wavelength range, for example, spanning 50nm or greater, such as 100nm or greater, such as 150nm or greater, such as 200nm or greater, such as 250nm or greater, such as 300nm or greater, such as 350nm or greater, such as 400nm or greater, and including spanning 500nm or greater. For example, a suitable broadband light source emits light with a wavelength from 200nm to 1500nm. Another example of a suitable broadband light source includes a light source emitting light with a wavelength of 400nm to 1000nm. When the method includes irradiating with a broadband light source, the target broadband light source scheme may include but is not limited to a halogen lamp, a deuterium arc lamp, a xenon arc lamp, a stabilized fiber-coupled broadband light source, a broadband LED with a continuous spectrum, a superluminescent diode, a semiconductor light emitting diode, a wide spectrum LED white light source, a multi-LED integrated white light source, and other broadband light sources or any combination thereof.

[0045] In other embodiments, the method includes irradiating with at least one narrowband light source emitting a specific wavelength or a narrow wavelength range, such as irradiating with a light source emitting light in a narrow wavelength range, such as a range of 50nm or less, such as 40nm or less, such as 30nm or less, such as 25nm or less, such as 20nm or less, such as 15nm or less, such as 10nm or less, such as 5nm or less, such as 2nm or less, and including a light source emitting light of a specific wavelength (i.e., monochromatic light). When the method includes irradiating with a narrowband light source, the target narrowband light source scheme can include, but is not limited to, a narrow wavelength LED, a laser diode, or a broadband light source coupled to one or more optical bandpass filters, diffraction gratings, monochromators, or any combination thereof.

[0046] Aspects of the present invention include collecting fluorescence with a fluorescence detector. In some cases, the fluorescence detector can be configured to detect the fluorescence emission from fluorescent molecules, such as the labeling specific binding members associated with the particles in the flow cell (for example, the labeled antibodies specifically bound to the target marker). In certain embodiments, the method includes detecting the fluorescence from the sample with one or more fluorescence detectors, such as 2 or more, 3 or more, 4 or more, 5 or more, 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, 15 or more and including 25 or more fluorescence detectors. In an embodiment, each of the fluorescence detectors is configured to generate a fluorescence data signal. Fluorescence from the sample can be detected independently by each fluorescence detector in one or more wavelength ranges of 200nm-1200nm. In some cases, the method includes detecting the fluorescence of the sample within a certain wavelength range, for example, from 200nm to 1200nm, for example, from 300nm to 1100nm, for example, from 400nm to 1000nm, for example, from 500nm to 900nm, and including from 600nm to 800nm. In other cases, the method includes using each fluorescence detector to detect fluorescence at one or more specific wavelengths. For example, according to the number of different fluorescence detectors in the light detection system of the present theme, fluorescence can be detected at one or more of 450nm, 518nm, 519nm, 561nm, 578nm, 605nm, 607nm, 625nm, 650nm, 660nm, 667nm, 670nm, 668nm, 695nm, 710nm, 723nm, 780nm, 785nm, 647nm, 617nm, and any combination thereof. In certain embodiments, the method includes detecting the wavelength of light corresponding to the fluorescence peak wavelength of some fluorescent dyes present in the sample. In an embodiment, fluorescence flow cytometry data is received from one or more fluorescence detectors (e.g., one or more detection channels), for example, 2 or more, for example, 3 or more, for example, 4 or more, for example, 5 or more, for example, 6 or more and including 8 or more fluorescence detectors (e.g., 8 or more detection channels).

[0047] In some cases, the sample analyzed is a particle sample. In other words, the sample includes multiple particles (e.g., cells, magnetic beads, polynucleotides, proteins, etc.). In some cases, the sample analyzed in the present method is a biological sample. The term "biological sample" refers to a subset of whole organisms, plants, fungi or animal tissues, cells or components in its conventional sense, and in some cases, they may be present in blood, mucus, lymph, synovial fluid, cerebrospinal fluid, saliva, bronchoalveolar lavage fluid, amniotic fluid, amniotic cord blood, urine, vaginal fluid and semen. Therefore, "biological sample" refers to both natural organisms or their tissue subsets, and also refers to homogenates, lysates or extracts prepared from organisms or their tissue subsets, including but not limited to, for example, plasma, serum, cerebrospinal fluid, lymph, skin slices, respiratory tract, gastrointestinal tract, cardiovascular and urogenital tracts, tears, saliva, milk, blood cells, tumors, organs. Biological samples can be any type of biological tissue, including healthy and diseased tissues (e.g., cancerous, malignant, necrotic, etc.). In certain embodiments, the biological sample is a liquid sample, such as blood or a derivative thereof, such as plasma, tears, urine, semen, etc., including in some cases where the sample is a blood sample, whole blood, such as blood obtained from a venipuncture or fingertip prick (wherein the blood may or may not be mixed with any reagents, such as preservatives, anticoagulants, etc., prior to assay).

[0048] In certain embodiments, the sample source is "mammal" or "mammals", which are terms widely used to describe organisms in the mammal class, including Carnivora (e.g., dogs and cats), Rodentia (e.g., mice, guinea pigs and rats), and primates (e.g., humans, chimpanzees and monkeys). In some cases, the subject is a human. The method can be applied to samples obtained from human subjects of both sexes and any developmental stage (i.e., newborns, infants, juveniles, adolescents, adults), wherein in certain embodiments, the human subject is a juvenile, adolescent or adult. Although the present invention can be applied to samples from human subjects, it should be understood that these methods can also be performed on samples from other animal subjects (i.e., "non-human subjects"), such as but not limited to birds, mice, rats, dogs, cats, livestock and horses.

[0049] Target cells can be targeted for characterization according to a variety of parameters, such as phenotypic features identified by attaching specific fluorescent markers to target cells. In certain embodiments, the system is configured to deflect analysis droplets determined to contain target cells. A variety of cells can be characterized using the method of this theme. Target cells include, but are not limited to, stem cells, T cells, dendritic cells, B cells, granulocytes, leukemia cells, lymphoma cells, viral cells (such as HIV cells), NK cells, macrophages, monocytes, fibroblasts, epithelial cells, endothelial cells, and erythrocytes. Target cells include cells with convenient cell surface markers or antigens, which can be captured or labeled by convenient affinity agents or their conjugates. For example, the target cell may include cell surface antigens such as CD11b, CD123, CD14, CD15, CD16, CD19, CD193, CD2, CD25, CD27, CD3, CD335, CD36, CD4, CD43, CD45RO, CD56, CD61, CD7, CD8, CD34, CD1c, CD23, CD304, CD235a, T cell receptor α / β, T cell receptor γ / δ, CD253, CD95, CD20, CD105, CD117, CD120b, Notch4, Lgr5 (N-terminal), SSEA-3, TRA-1-60 antigen, disialoganglioside GD2, and CD71. In some embodiments, the target cell is selected from cells containing HIV, Treg cells, antigen-specific T cell populations, tumor cells, or hematopoietic stem cells (CD34+) from whole blood, bone marrow, or umbilical cord blood.

[0050] The target method can also include the use of particles in research, laboratory testing or treatment. In certain embodiments, the method of this theme includes obtaining single cells prepared from samples of target fluid or tissue biology. For example, the method of this theme includes obtaining cells from fluid or tissue samples for use as research or diagnostic samples for diseases such as cancer. Similarly, the method of this theme includes obtaining cells from fluid or tissue samples for treatment. Cell therapy protocols are wherein living cell materials including, for example, cells and tissues can be prepared and introduced into the subject as a treatment protocol. Diseases that can be treated by administering samples sorted by flow cytometry include, but are not limited to, blood diseases, immune system diseases, organ damage, etc.

[0051] Typical cell therapy protocols may include the following steps: sample collection, cell separation, genetic modification, culture and in vitro amplification, cell harvesting, sample volume reduction and cleaning, biological preservation, storage and introduction of cells into the subject. The protocol can start with the collection of living cells and tissues from the source tissue of the subject to produce cell and / or tissue samples. The sample can be collected by any suitable procedure, including, for example, administering a cell mobilization agent to the subject, extracting blood from the subject, removing bone marrow from the subject, etc. After collecting the sample, cell enrichment can be performed by several methods, including, for example, centrifugation-based methods, filter-based methods, elutriation, magnetic separation methods, fluorescence-activated cell sorting (FACS) and similar methods. In some cases, the enriched cells can be genetically modified by any convenient method, such as nuclease-mediated gene editing. Genetically modified cells can be cultured, activated and amplified in vitro. In some cases, the cells are preserved (e.g., cryopreserved) and stored for future use, in which the cells are thawed and then applied to the patient, for example, the cells can be injected into the patient.

[0052] Systems for evaluating flow cytometry data

[0053] Aspects of the present invention also include systems (e.g., flow cytometers) for evaluating flow cytometer data. The target system includes a flow cell configured to transport a particle sample in a flow stream, first and second light sources configured to illuminate a first particle and a second particle in the particle sample, respectively, a detector configured to generate flow cytometer data associated with the first particle, and a processor configured to evaluate the flow cytometer data. The target processor is configured to receive flow cytometer data associated with the illuminated first particle from the detector, as well as a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. In addition, the processor of the present subject matter generates a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and based on the generated time interval, evaluates the obtained flow cytometer data for the presence of a coincidence event by determining whether the first particle and the second particle are illuminated by the first and second light sources at the same time.

[0054] As described herein, "flow cell" is described in its conventional sense to refer to a component (e.g., a cuvette) comprising a flow channel having a liquid flow stream for transporting particles in a sheath fluid. The target cuvette comprises a container having a channel running therethrough. The flow stream may include a liquid sample injected from a sample tube. The target flow cell comprises a flow channel into which light can enter. In some cases, the flow cell comprises a transparent material (e.g., quartz) that allows light to pass. In some embodiments, the flow cell is an air flow cell, in which optical interrogation of particles occurs in free space. In some cases, the flow stream is configured to be irradiated with light from a first light source and a second light source at an interrogation zone (e.g., those described above). The flow stream for which the flow channel is configured may include a liquid sample injected from a sample tube. In some embodiments, the flow stream may include a narrow, fast-flowing liquid stream arranged so that linearly separated particles transported therein are separated from each other in a single-file manner. After irradiating particles in the flow cell, particle modulated light may be observed. "Particle modulated light" refers to light received from particles in the flow stream after irradiating particles with light from a light source. In some cases, the particle modulated light is side scattered light. As described herein, side scattered light refers to light refracted and reflected from the surface and internal structure of the particle. In other embodiments, the particle modulated light includes forward scattered light (i.e., light that passes through or around the particle primarily in the forward direction). In other cases, the particle modulated light includes fluorescence (i.e., light emitted from a fluorescent dye after being irradiated with light of an excitation wavelength).

[0055] In some cases, the processor of the present subject matter operates with programmable logic, which can be implemented in hardware, software, firmware, or any combination thereof, so as to evaluate flow cytometer data, for example, for the presence of coincident events. For example, when the programmable logic is implemented in software, evaluating the flow cytometer data for the presence of coincident events is implemented at least in part by a computer-readable data storage medium, the computer-readable data storage medium comprising a program code, the program code comprising instructions, when executed, the instructions are configured to receive flow cytometer data associated with an irradiated first particle from a detector, and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. The program code may also include instructions for generating a time interval for the first particle and the second particle based on a difference between the first trigger and the second trigger signal. For example, where t1 is a time point associated with the first trigger signal and t2 is a time point associated with the second trigger signal, the time interval can be calculated by finding |t2-t1|. In some cases, the time interval represents the amount of time that has passed between the time point at which the first particle is detected in the fluid flow (i.e., the first trigger signal) and the time point at which the second particle is detected in the fluid flow (i.e., the second trigger signal). The program code may also include instructions for evaluating the acquired flow cytometer data for the presence of a coincidence event by determining whether the first particle and the second particle were illuminated by the first and second light sources at the same time based on the generated time interval. In some cases, evaluating the flow cytometer data includes comparing the time interval with a measurement window associated with the second light source, such as by determining, based on the time interval, whether the second particle fell within the measurement window associated with the second light source when the flow cytometer data associated with the first particle was acquired from the detector. In other cases, evaluating the flow cytometer data includes comparing the time interval with a standard value, such as by determining whether the time interval is below the standard value.

[0056] When the programmable logic identifies a coincidence event, the processor of the present subject matter can also be configured to modify the affected flow cytometer data. In some cases, modifying the evaluated flow cytometer data includes ignoring the flow cytometer data containing the coincidence event (i.e., removing the affected flow cytometer data from the rest of the data collected in the experiment). In other embodiments, the method includes assigning a coincidence identifier to the flow cytometer data containing the coincidence event. In other words, the affected flow cytometer data is marked as potentially compromised. The individual interpreting the flow cytometer data can then make an informed assessment of the impact of these data on data quality.

[0057] The programmable logic of the present subject matter may be implemented in a variety of devices, such as specially programmed event processing computers, wireless communication devices, integrated circuit devices, etc. In some embodiments, the programmable logic may be executed by a specially programmed processor, which may include one or more processors, such as one or more digital signal processors (DSPs), configurable microprocessors, application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or other equivalent integrated or discrete logic circuits. A combination of computing devices, such as a combination of a DSP and a microprocessor, a plurality of microprocessors, a combination of one or more microprocessors with a DSP core, or any other such configuration in at least some data connections, may implement one or more features described herein.

[0058] In some cases, the system also includes a display configured to output the flow cytometer data evaluated by the processor. A user can then view the flow cytometer data evaluated by the processor. The display of the present subject matter may include, but is not limited to, a monitor, a tablet computer, a smart phone, or other electronic device configured to present a graphical interface.

[0059] As described above, aspects of the present invention also include a first light source and a second light source, which are configured to irradiate particles passing through the flow cell at the interrogation point. Any convenient light source can be used as the first light source and the second light source described herein. In some embodiments, one or more light sources are lasers. In an embodiment, the laser can be any convenient laser, such as a continuous wave laser. For example, the laser can be a diode laser, such as an ultraviolet diode laser, a visible diode laser, and a near-infrared diode laser. In other embodiments, the laser can be a helium-neon (HeNe) laser. In some cases, the laser is a gas laser, such as a helium-neon laser, an argon laser, a krypton laser, a xenon laser, a nitrogen laser, a CO2 laser, a CO laser, an argon-fluorine (ArF) excimer laser, a krypton-fluorine (KrF) excimer laser, a xenon-chlorine (XeCl) excimer laser, or a xenon-fluorine (XeF) excimer laser or a combination thereof. In other cases, the flow cytometer of this subject includes a dye laser, such as a stilbene, a coumarin, or a rhodamine laser. In other cases, the target laser includes a metal vapor laser, such as a helium cadmium (HeCd) laser, a helium mercury (HeHg) laser, a helium selenium (HeSe) laser, a helium silver (HeAg) laser, a strontium laser, a neon copper (NeCu) laser, a copper laser, or a gold laser, and combinations thereof. In other cases, the flow cytometer of the present subject matter includes a solid-state laser, such as a ruby ​​laser, a Nd:YAG laser, a NdCrYAG laser, an Er:YAG laser, a Nd:YLF laser, a Nd:YVO4 laser, a Nd:YCa4O(BO3)3 laser, a Nd:YCOB laser, a titanium sapphire laser, a thulium YAG laser, an ytterbium YAG laser, an ytterbium 2 O3 laser, or a cerium-doped laser, and combinations thereof.

[0060] The laser light source according to some embodiments may also include one or more optical adjustment components. In some embodiments, the optical adjustment component is located between the light source and the flow cell, and may include any device capable of changing the spatial width of the irradiation or some other characteristics of the irradiation from the light source, such as the irradiation direction, wavelength, beam width, beam intensity, and focus. The optical adjustment scheme may include any convenient device for adjusting one or more characteristics of the light source, including but not limited to lenses, mirrors, filters, optical fibers, wavelength separators, pinholes, slits, collimation sensors, and combinations thereof. In some embodiments, the target flow cytometer includes one or more focusing lenses. In one example, the focusing lens can be a zoom lens. In other embodiments, the target flow cytometer includes an optical fiber.

[0061] When the optical adjustment component is configured to move, the optical adjustment component can be configured to move continuously or in discrete intervals, for example, in increments of 0.01 μm or greater, for example 0.05 μm or greater, for example 0.1 μm or greater, for example 0.5 μm or greater, for example 1 μm or greater, for example 10 μm or greater, for example 100 μm or greater, for example 500 μm or greater, for example 1 mm or greater, for example 5 mm or greater, for example 10 mm or greater and including increments of 25 mm or greater.

[0062] Any displacement scheme can be used to move the optical adjustment component structure, such as coupling to a movable support table or directly coupled to a motor-driven translation stage, a screw translation assembly, a gear translation device, such as those using stepper motors, servo motors, brushless motors, brushed DC motors, micro-step drive motors, high-resolution stepper motors, and other types of motors.

[0063] The light source may be located at any suitable distance from the flow cell, for example, the light source is separated from the flow cell by 0.005 mm or more, for example, 0.01 mm or more, for example, 0.05 mm or more, for example, 0.1 mm or more, for example, 0.5 mm or more, for example, 1 mm or more, for example, 5 mm or more, for example, 10 mm or more, for example, 25 mm or more, and including a distance of 100 mm or more. In addition, the light source may be located at any suitable angle relative to the flow cell, for example, an angle in the range of 10 to 90 degrees, for example, an angle in the range of 15 to 85 degrees, for example, an angle in the range of 20 to 80 degrees, for example, an angle in the range of 25 to 75 degrees, and including an angle in the range of 30 to 60 degrees, for example, an angle of 90 degrees.

[0064] In some embodiments, the target light source includes a plurality of lasers configured to provide laser light to separately illuminate the flow stream, such as 2 lasers or more, such as 3 lasers or more, such as 4 lasers or more, such as 5 lasers or more, such as 10 lasers or more, and including 15 lasers or more, which are configured to provide laser light to separately illuminate the flow stream. Depending on the wavelength of the required light for illuminating the flow stream, each laser can have a specific wavelength that varies from 200nm to 1500nm, such as from 250nm to 1250nm, such as from 300nm to 1000nm, such as from 350nm to 900nm and including from 400nm to 800nm. In some embodiments, the target laser can include one or more of a 405nm laser, a 488nm laser, a 561nm laser, and a 635nm laser.

[0065] As described above, the target particle analyzer may also include one or more detectors for detecting particle modulated light intensity data. In some embodiments, the particle modulated light detector includes one or more forward scattered light detectors configured to detect forward scattered light. For example, the target particle analyzer may include 1 forward scattered light detector or multiple forward scattered light detectors, such as 2 or more, such as 3 or more, such as 4 or more, and including 5 or more. In some embodiments, the particle analyzer includes 1 forward scattered light detector. In other embodiments, the particle analyzer includes 2 forward scattered light detectors.

[0066] Any convenient detector for detecting collected light can be used for the forward scattered light detector described herein. The target detector may include, but is not limited to, an optical sensor or detector, such as an active pixel sensor (APS), an avalanche photodiode, an image sensor, a charge coupled device (CCD), an enhanced charge coupled device (ICCD), a light emitting diode, a photon counter, a bolometer, a pyroelectric detector, a photoresistor, a photovoltaic cell, a photodiode, a photomultiplier tube (PMT), a phototransistor, a quantum dot photoconductor or a photodiode and a combination thereof, and other detectors. In certain embodiments, the collected light is measured with a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector is a photomultiplier tube, for example, each region has an effective detection surface area of ​​0.01 cm 2 Up to 10cm 2 Photomultiplier tube, for example, 0.05 cm 2 Up to 9cm 2 , for example 0.1 cm 2 Up to 8cm 2 , for example 0.5 cm 2 Up to 7cm 2 , and includes 1cm 2 Up to 5cm 2 .

[0067] In embodiments, the forward scattered light detector is configured to measure light continuously or at discrete intervals. In some cases, the target detector is configured to measure the collected light continuously. In other cases, the target detector is configured to measure at discrete intervals, such as every 0.001 milliseconds, every 0.01 milliseconds, every 0.1 milliseconds, every 1 millisecond, every 10 milliseconds, every 100 milliseconds, and including every 1000 milliseconds, or some other interval.

[0068] In further embodiments, the one or more detectors may include one or more side scattered light detectors for detecting wavelengths of side scattered light (i.e., light refracted and reflected from the surface and internal structure of the particles). In some embodiments, the particle analyzer includes a single side scattered light detector. In other embodiments, the particle analyzer includes multiple side scattered light detectors, such as 2 or more, such as 3 or more, such as 4 or more, and including 5 or more.

[0069] Any convenient detector for detecting collected light can be used for the side scattered light detector described herein. The target detector can include, but is not limited to, an optical sensor or detector, such as an active pixel sensor (APS), an avalanche photodiode, an image sensor, a charge coupled device (CCD), an enhanced charge coupled device (ICCD), a light emitting diode, a photon counter, a bolometer, a pyroelectric detector, a photoresistor, a photovoltaic cell, a photodiode, a photomultiplier tube (PMT), a phototransistor, a quantum dot photoconductor or photodiode and combinations thereof, and other detectors. In certain embodiments, the collected light is measured using a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector is a photomultiplier tube, for example, each region having an effective detection surface area of ​​0.01 cm 2 Up to 10cm 2 Photomultiplier tube, for example, 0.05 cm 2 Up to 9cm 2 , for example, 0.1 cm 2 Up to 8cm 2 , for example, 0.5 cm 2 Up to 7cm 2 , and includes 1cm 2 Up to 5cm 2 .

[0070] In an embodiment, the particle analyzer of the present subject matter further comprises a fluorescence detector configured to detect one or more fluorescent wavelengths of light. In other embodiments, the particle analyzer comprises a plurality of fluorescence detectors, such as 2 or more, such as 3 or more, such as 4 or more, 5 or more, 10 or more, 15 or more, and including 20 or more.

[0071] Any convenient detector for detecting collected light can be used for the fluorescence detector described herein. The target detector may include, but is not limited to, an optical sensor or detector, such as an active pixel sensor (APS), an avalanche photodiode, an image sensor, a charge coupled device (CCD), an enhanced charge coupled device (ICCD), a light emitting diode, a photon counter, a bolometer, a pyroelectric detector, a photoresistor, a photovoltaic cell, a photodiode, a photomultiplier tube (PMT), a phototransistor, a quantum dot photoconductor or photodiode, and combinations thereof, and other detectors. In certain embodiments, the collected light is measured using a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector is a photomultiplier tube, for example, with an effective detection surface area of ​​0.01 cm per region. 2 Up to 10cm 2 Photomultiplier tube, for example, 0.05 cm 2 Up to 9cm 2 , for example, 0.1 cm 2 Up to 8cm 2 , for example, 0.5 cm 2 Up to 7cm 2 , and includes 1cm 2 Up to 5cm 2 .

[0072] When the particle analyzer of the present subject matter includes multiple fluorescent photodetectors, each fluorescent photodetector can be identical, or the collection of fluorescent photodetectors can be a combination of different types of detectors. For example, when the particle analyzer of the present subject matter includes two fluorescent photodetectors, in some embodiments, the first fluorescent photodetector is a CCD type device, and the second fluorescent photodetector (or imaging sensor) is a CMOS type device. In other embodiments, the first fluorescent photodetector and the second fluorescent photodetector are both CCD type devices. In other embodiments, the first fluorescent photodetector and the second fluorescent photodetector are both CMOS type devices. In other embodiments, the first fluorescent photodetector is a CCD type device, and the second fluorescent photodetector is a photomultiplier tube (PMT). In other embodiments, the first fluorescent photodetector is a CMOS type device, and the second fluorescent photodetector is a photomultiplier tube. In other embodiments, the first fluorescent photodetector and the second fluorescent photodetector are both photomultiplier tubes.

[0073] In embodiments of the present disclosure, the target fluorescence light detector is configured to measure the collected light at one or more wavelengths, such as 2 or more wavelengths, such as 5 or more different wavelengths, such as 10 or more different wavelengths, such as 25 or more different wavelengths, such as 50 or more different wavelengths, such as 100 or more different wavelengths, such as 200 or more different wavelengths, such as 300 or more different wavelengths, and includes measuring the light emitted by the sample in the flow stream at 400 or more different wavelengths. In some embodiments, 2 or more detectors in the particle analyzer described herein are configured to measure the collected light of the same or overlapping wavelengths.

[0074] In some embodiments, the target fluorescence light detector is configured to measure light collected within a certain wavelength range (e.g., 200nm-1000nm). In some embodiments, the target detector is configured to collect a spectrum of light within a certain wavelength range. For example, the particle analyzer may include one or more detectors configured to collect a spectrum of light within one or more wavelength ranges of 200nm-1000nm. In some further embodiments, the target detector is configured to measure light emitted by a sample in a flow stream at one or more specific wavelengths. For example, the particle analyzer may include one or more detectors configured to measure light of one or more wavelengths in the following wavelengths: 450nm, 518nm, 519nm, 561nm, 578nm, 605nm, 607nm, 625nm, 650nm, 660nm, 667nm, 670nm, 668nm, 695nm, 710nm, 723nm, 780nm, 785nm, 647nm, 617nm and any combination thereof. In certain embodiments, one or more detectors may be configured to pair with a specific fluorophore, such as a fluorophore to be used with a sample in a fluorescence assay.

[0075] In some embodiments, one or more particle modulated light detectors include one or more detector arrays, such as photodiode arrays. In these embodiments, each detector array may include 4 or more detectors, such as 10 or more detectors, such as 25 or more detectors, such as 50 or more detectors, such as 100 or more detectors, such as 250 or more detectors, such as 500 or more detectors, such as 750 or more detectors, and including 1000 or more detectors. For example, the detector may be a photodiode array having 4 or more photodiodes, such as 10 or more photodiodes, such as 25 or more photodiodes, such as 50 or more photodiodes, such as 100 or more photodiodes, such as 250 or more photodiodes, such as 500 or more photodiodes, such as 750 or more photodiodes, and including 1000 or more photodiodes.

[0076] The detectors can be arranged in any geometric structure as required, where target arrangements include but are not limited to square configurations, rectangular configurations, trapezoidal configurations, triangular configurations, hexagonal configurations, heptagonal configurations, octagonal configurations, nonagonal configurations, decagonal configurations, dodecagonal configurations, circular configurations, elliptical configurations, and irregular pattern configurations. The detectors in the detector array can be oriented at angles relative to each other (with reference to the XZ plane) in the range of 10° to 180°, such as 15° to 170°, such as 20° to 160°, such as 25° to 150°, such as 30° to 120°, including 45° to 90°. The detector array can be of any suitable shape, which can be a straight line shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., or a curved shape, such as a circle, ellipse, or an irregular shape, such as a parabolic bottom coupled to a flat top. In some embodiments, the detector array has a rectangular effective surface.

[0077] In some embodiments, the particle analyzer includes one or more wavelength separators, which are located between the flow cell and the particle modulated light detector. The term "wavelength separator" is used in its conventional sense herein and refers to an optical component configured to separate the light collected from the sample into a predetermined spectral range. In some embodiments, the particle analyzer includes a single wavelength separator. In other embodiments, the particle analyzer includes a plurality of wavelength separators, such as 2 or more wavelength separators, such as 3 or more, such as 4 or more, such as 5 or more, such as 6 or more, such as 7 or more, such as 8 or more, such as 9 or more, such as 10 or more, such as 15 or more, such as 25 or more, such as 50 or more, such as 75 or more and including 100 or more wavelength separators. In some embodiments, the wavelength separator is configured to separate the light collected from the sample into a predetermined spectral range by passing light with a predetermined spectral range and reflecting light of one or more remaining spectral ranges. In other embodiments, the wavelength separator is configured to separate the light collected from the sample into a predetermined spectral range by passing light having a predetermined spectral range and absorbing light of one or more remaining spectral ranges. In other embodiments, the wavelength separator is configured to spatially diffract the light collected from the sample into a predetermined spectral range. Each wavelength separator can be any convenient light separation scheme, such as one or more dichroic mirrors, bandpass filters, diffraction gratings, beam splitters, or prisms. In some embodiments, the wavelength separator is a prism. In other embodiments, the wavelength separator is a diffraction grating. In certain embodiments, the wavelength separator in the light detection system of the present subject is a dichroic mirror.

[0078] As described above, aspects of the flow cytometer of the present subject matter include a flow cell configured to propagate particles in a flow stream. Any convenient flow cell that propagates a fluid sample to a sample interrogation zone may be employed, wherein in some embodiments, the flow cell comprises a cylindrical flow cell, a frustoconical flow cell, or a flow cell comprising a proximal cylindrical portion defining a longitudinal axis and a distal frustoconical portion terminating in a flat surface, wherein the flat surface has an orifice transverse to the longitudinal axis.

[0079] In some embodiments, the sample flow stream flows out of an orifice at the distal end of the flow cell. Depending on the desired characteristics of the flow stream, the flow cell orifice can be any suitable shape, wherein the target cross-sectional shape includes, but is not limited to: a straight cross-sectional shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., a curved cross-sectional shape, such as a circle, an ellipse, and an irregular shape, such as a parabolic bottom coupled with a flat top. In some embodiments, the target flow cell has a circular orifice. The size of the nozzle hole can vary, and in some embodiments, ranges from 1 μm to 10000 μm, such as from 25 μm to 7500 μm, such as from 50 μm to 5000 μm, such as from 75 μm to 1000 μm, such as from 100 μm to 750 μm, and includes from 150 μm to 500 μm. In some embodiments, the nozzle hole is 100 μm.

[0080] In some embodiments, the flow cell includes a sample injection port, which is configured to provide a sample to the flow cell. The sample injection port can be an orifice located in the inner cavity wall, or can be a catheter located at the proximal end of the inner cavity. When the sample injection port is an orifice located in the inner cavity wall, the sample injection port orifice can be any suitable shape, wherein the target cross-sectional shape includes but is not limited to: a straight cross-sectional shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., a curved cross-sectional shape, such as a circle, an ellipse, etc., and an irregular shape, such as a parabola bottom coupled to a plane top. In certain embodiments, the sample injection port has a circular orifice. The size of the sample injection port orifice can vary according to the shape, and in certain cases, the opening range is 0.1mm to 5.0mm, such as 0.2 to 3.0mm, such as 0.5mm to 2.5mm, such as 0.75mm to 2.25mm, such as 1mm to 2mm, and includes 1.25mm to 1.75mm, such as 1.5mm.

[0081] In some cases, the sample injection port is a catheter located at the proximal end of the flow cell lumen. For example, the sample injection port can be a catheter located so that the orifice of the sample injection port is aligned with the orifice of the flow cell. When the sample injection port is a catheter located in alignment with the orifice of the flow cell, the cross-sectional shape of the sample injection tube can be any suitable shape, wherein the target cross-sectional shape includes but is not limited to: a straight cross-sectional shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., a curved cross-sectional shape, such as a circle, an ellipse, and an irregular shape, such as a parabola bottom coupled to a plane top. The orifice of the catheter can vary according to the shape, and in some cases, its opening range is 0.1mm to 5.0mm, such as 0.2 to 3.0mm, such as 0.5mm to 2.5mm, such as 0.75mm to 2.25mm, such as 1mm to 2mm, including 1.25mm to 1.75mm, such as 1.5mm. The shape of the tip of the sample injection port can be the same or different from the cross-sectional shape of the sample injection tube. For example, the orifice of the sample injection port may include a bevel tip having a bevel angle ranging from 1 degree to 10 degrees, such as 2 degrees to 9 degrees, such as 3 degrees to 8 degrees, such as 4 degrees to 7 degrees, and including a bevel angle of 5 degrees.

[0082] In some embodiments, the flow cell further comprises a sheath injection port configured to provide sheath fluid to the flow cell. In embodiments, the sheath injection system is configured to provide a sheath fluid flow to the lumen of the flow cell, such as to generate a laminar sheath fluid flow around the sample flow stream together with the sample. Depending on the desired characteristics of the flow stream, the sheath fluid rate delivered to the flow cell can be 25 μL / sec to 2500 μL / sec, such as 50 μL / sec to 1000 μL / sec, and includes 75 μL / sec or higher to 750 μL / sec.

[0083] In some embodiments, the sheath injection port is an orifice located on the inner cavity wall. The sheath injection port orifice can be any suitable shape, where the target cross-sectional shape includes, but is not limited to: a straight cross-sectional shape, such as a square, rectangle, trapezoid, triangle, hexagon, etc., a curved cross-sectional shape, such as a circle, an ellipse, and an irregular shape, such as a parabola bottom coupled with a flat top. The size of the sample injection port orifice can vary depending on the shape, and in some cases, the opening ranges from 0.1 mm to 5.0 mm, such as 0.2 to 3.0 mm, such as 0.5 mm to 2.5 mm, such as 0.75 mm to 2.25 mm, such as 1 mm to 2 mm, and includes 1.25 mm to 1.75 mm, such as 1.5 mm.

[0084] In some embodiments, the system also includes a pump connected to the flow cell fluid so that the flow stream passes through the flow cell. Any convenient fluid pump scheme can be used to control the flow of the flow stream through the flow cell. In some cases, the system includes a peristaltic pump, such as a peristaltic pump with a pulse damper. The pump in the system of this theme is configured to transport the flow stream through the flow cell at a rate suitable for multi-photon counting of the light from the sample in the flow stream. For example, the system may include a pump that is configured to make the sample flow through the flow cell at a rate of 1nL / min to 500nL / min, such as 1nL / min to 250nL / min, such as 1nL / min to 100nL / min, such as 2nL / min to 90nL / min, such as 3nL / min to 80nL / min, such as 4nL / min to 70nL / min, such as 5nL / min to 60nL / min, and including 10nL / min to 50nL / min. In certain embodiments, the flow rate of the flow stream is 5 nL / min to 6 nL / min.

[0085] Suitable flow cytometry systems may include, but are not limited to, those described in Ormerod (ed.), Flow Cytometry: A Practical Approach, Oxford University Press (1994); Jaroszeski et al. (eds.), Flow Cytometry Protocols, Methods in Molecular Biology, Vol. 91, Humana Press (1997); Practical Flow Cytometry, 3rd ed., Wiley-Liss (1995); Virgo et al. (2012) Ann Clin Biochem. Jan;49(Part 1):17-28; Linden et al., Semin Throm Hemost. Oct. 2004;30(5):502-11; Alison et al., J Pathol, Dec. 2010;222(4):335-344; and Herbig et al., (2007) Crit Rev Ther Drug Carrier Syst. 24(3):203-255; the disclosure of which is incorporated herein by reference. In some cases, the flow cytometry system of interest includes a BD Biosciences FACSCanto TM Flow cytometer, BD Biosciences FACSCanto TM II flow cytometer, BD Accuri TM Flow cytometer, BD Accuri TM C6 Plus flow cytometer, BD Biosciences FACSCelesta TMFlow cytometer, BD Biosciences FACSLyric TM Flow cytometer, BD Biosciences FACSVerse TM Flow cytometer, BD Biosciences FACSymphony TM Flow cytometer, BD Biosciences LSRFortessa TM Flow cytometer, BD Biosciences LSRFortessa TM X-20 flow cytometer, BD Biosciences FACSPresto TM Flow cytometer, BD Biosciences FACSVia TM Flow cytometer and BD Biosciences FACSCalibur TM Cell sorter, BD Biosciences FACSCount TM Cell sorter, BD Biosciences FACSLyric TM Cell sorter, BD Biosciences Via TM Cell sorter, BD Biosciences Influx TM Cell sorter, BD Biosciences Jazz TM Cell sorter, BD BiosciencesAria TM Cell sorter, BD Biosciences FACSAria TM II cell sorter, BD Biosciences FACSAria TM III cell sorter, BD Biosciences FACSAria TM Fusion Cell Sorter and BD Biosciences FACSMelody TM Cell sorter, BD Biosciences FACSymphony TM S6 cell sorter or similar.

[0086] In some embodiments, the subject system is a flow cytometry system, such as the systems described in U.S. Pat. Nos. 10,663,476, 10,620,111, 10,613,017, 10,605,713, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,302,545, 10,145,793, 10,113,967, 10,006,852, 9,952,076, 9,933,341, 9,726,527, 9,453,789, 9,200,334, 9,097,640 , No. 9,095,494, No. 9,092,034, No. 8,975,595, No. 8,753,573, No. 8,233,146, No. 8,140,300, No. 7,544,326, No. 7,201,875, No. 7,129,505, No. 6,821,740, No. 6,813,017 No. 6,809,804, No. 6,372,506, No. 5,700,692, No. 5,643,796, No. 5,627,040, No. 5,620,842, No. 5,602,039, No. 4,987,086, No. 4,498,766; the disclosures of which are incorporated herein by reference in their entirety.

[0087] In some cases, the flow cytometry system of the present invention is configured to image particles in a flow stream by fluorescence imaging using radio frequency labeled emission (FIRE), as described in Diebold et al., Nature Photonics, Vol. 7(10); 806-810 (2013) and Nos. 9,423,353, 9,784,661, 9,983,132, 10,006,852, 10,078,045, 10,036,699, 10,222,31 6, 10,288,546, 10,324,019, 10,408,758, 10,451,538, 10,620,111; and U.S. Patent Publication Nos. 2017 / 0133857, 2017 / 0328826, 2017 / 0350803, 2018 / 0275042, 2019 / 0376895, and 2019 / 0376894; the disclosures of the said U.S. patents are incorporated herein by reference.

[0088] Figure 3A system 300 for flow cytometry according to an exemplary embodiment of the present invention is shown. The system 300 includes a flow cytometer 310, a controller / processor 390, and a memory 395. The flow cytometer 310 includes one or more excitation lasers 315a-315c, a focusing lens 320, a flow chamber 325, a forward scatter detector 330, a side scatter detector 335, a fluorescence collection lens 340, one or more beam splitters 345a-345g, one or more bandpass filters 350a-350e, one or more long pass ("LP") filters 355a-355b, and one or more fluorescence detectors 360a-360f.

[0089] The excitation lasers 315a-c emit light in the form of laser beams. Figure 3 In the example system of , the wavelengths of the laser beams emitted by the excitation lasers 315a-315c are 488nm, 633nm and 325nm, respectively. The laser beams are first directed through one or more beam splitters 345a and 345b. Beam splitter 345a transmits 488nm light and reflects 633nm light. Beam splitter 345b transmits ultraviolet light (light with a wavelength range of 10 to 400nm) and reflects 488nm and 633nm light.

[0090] The laser beam is then directed to a focusing lens 320 which focuses the beam onto the portion of the flow stream where the sample particles are located within a flow cell 325. The flow cell is the portion of the fluidic system that directs the particles in the stream (usually one at a time) toward the focused laser beam for interrogation. The flow cell may include a flow cell in a benchtop cytometer or a nozzle head in an air flow cytometer.

[0091] Light from the laser beam interacts with particles in the sample through diffraction, refraction, reflection, scattering, and absorption, and is re-emitted at various wavelengths depending on the characteristics of the particle, such as its size, internal structure, and the presence of one or more fluorescent molecules attached to or naturally present on or within the particle. The fluorescent emission, as well as the diffracted, refracted, reflected, and scattered light, can be routed to one or more forward scatter detectors 330, side scatter detector 335, and one or more fluorescence detectors 360a-360f through one or more of beam splitters 345c-345g, bandpass filters 350a-350e, longpass filters 355a-355b, and fluorescence collection lens 340.

[0092] The fluorescence collection lens 340 collects the light emitted by the particle laser beam interaction and directs the light to one or more beam splitters and filters. Bandpass filters (e.g., bandpass filters 350a-350e) allow a narrow range of wavelengths to pass through the filter. For example, bandpass filter 350a is a 510 / 20 filter. The first number represents the center of the spectral band. The second number provides the range of the spectral band. Therefore, the 510 / 20 filter extends 10nm on each side of the center of the spectral band, or extends from 500nm to 520nm. Short-pass filters transmit light with a wavelength equal to or shorter than a specified wavelength. Long-pass filters (e.g., long-pass filters 355a-355b) transmit light with a wavelength equal to or longer than a specified wavelength. For example, long-pass filter 355b is a 670nm long-pass filter that transmits light with a wavelength equal to or longer than 670nm. Filters are typically selected to optimize the specificity of the detector for a particular fluorescent dye. The filter can be configured to transmit to the detector a spectral band of light close to the emission peak of the fluorescent dye.

[0093] The forward scattering detector 330 is located at a slightly deflected position outside the axis of the direct beam passing through the flow cell, and is configured to detect diffracted light, that is, excitation light that passes through or bypasses the particles mainly in the forward direction. The intensity of the light detected by the forward scattering detector depends on the overall size of the particles. The forward scattering detector may include a photodiode. The side scattering detector 335 is configured to detect refracted and reflected light from the surface and internal structure of the particles, which increases as the complexity of the particle structure increases. Fluorescence emission from fluorescent molecules associated with the particles can be detected by one or more fluorescence detectors 360a-360f. The side scattering detector 335 and the fluorescence detector may include a photomultiplier tube. The signals detected by the forward scattering detector 330, the side scattering detector 335 and the fluorescence detector may be converted into electronic signals (voltages) by the detectors. The data may provide information about the sample.

[0094] The skilled person will recognize that the flow cytometer according to embodiments of the present invention is not limited to Figure 3 The flow cytometer shown in the flow cytometer may include any flow cytometer known in the art. For example, the flow cytometer may have any number of lasers, beam splitters, filters, and detectors, with various wavelengths and various different configurations.

[0095] In operation, the cytometer operation is controlled by the controller / processor 390, and the measurement data from the detector can be stored in the memory 395 and processed by the controller / processor 390. Although not explicitly shown, the controller / processor 390 is coupled to the detector to receive output signals therefrom, and can also be coupled to the electrical and electromechanical components of the flow cytometer 310 to control lasers, fluid flow parameters, etc. An input / output (I / O) function 397 may also be provided in the system. The memory 395, the controller / processor 390, and the I / O 397 may be provided entirely as an integral part of the flow cytometer 310. In such an embodiment, the display may also form part of the I / O function 397 for presenting experimental data to the user of the cytometer 310. Alternatively, some or all of the memory 395 and the controller / processor 390 and the I / O function may be part of one or more external devices (e.g., a general purpose computer). In some embodiments, some or all of the memory 395 and the controller / processor 390 may communicate wirelessly or wired with the cytometer 310. Controller / processor 390, together with memory 395 and I / O 397, may be configured to perform various functions associated with the preparation and analysis of flow cytometric experiments.

[0096] Figure 3 The system shown in 397 includes six different detectors that detect fluorescence in six different wavelength bands (which may be referred to herein as "filter windows" for a given detector), which are defined by the configuration of filters and / or spectrometers in the beam path from the flow cell 325 to each detector. Different fluorescent molecules used in flow cytometer experiments will emit light in their own characteristic wavelength bands. The specific fluorescent markers used in the experiment and their associated fluorescence emission bands can be selected to be roughly consistent with the filter windows of the detectors. I / O 397 can be configured to receive data about a flow cytometer experiment, which has a set of fluorescent markers and multiple cell populations with multiple markers, each cell population having a subset of multiple markers. I / O 397 can also be configured to receive biological data that assigns one or more markers to one or more cell populations, marker density data, emission spectrum data, data that assigns labels to one or more markers, and cytometer configuration data. Flow cytometer experiment data (such as label spectral characteristics and flow cytometer configuration data) can also be stored in memory 395. The controller / processor 390 may be configured to evaluate one or more assignments of tags to labels.

[0097] In some embodiments, the subject system is a particle sorting system configured to sort particles using a closed particle sorting module, such as those described in U.S. Patent Publication No. 2017 / 0299493, filed on March 28, 2017, the disclosure of which is incorporated herein by reference. In certain embodiments, particles (e.g., cells) of a sample are sorted using a sorting decision module having multiple sorting decision units, such as those described in U.S. Patent Publication No. 2020 / 0256781, filed on December 23, 2019, the disclosure of which is incorporated herein by reference. In some embodiments, a system for sorting components of a sample includes a particle sorting module having a deflection plate, such as those described in U.S. Patent Publication No. 2017 / 0299493, filed on March 28, 2017, the disclosure of which is incorporated herein by reference.

[0098] Figure 4 A functional block diagram of one example of a system, such as a processor 400, for analyzing and displaying biological events is shown. The processor 400 may be configured to implement various processes for controlling a graphical display of biological events.

[0099] The flow cytometer or sorting system 402 can be configured to acquire biological event data. For example, the flow cytometer can generate flow cytometer event data (e.g., particle modulated light data). The flow cytometer 402 can be configured to provide the biological event data to the processor 400. A data communication channel can be included between the flow cytometer 402 and the processor 400. The biological event data can be provided to the processor 400 via the data communication channel.

[0100] The processor 400 may be configured to receive biological event data from the flow cytometer 402. The biological event data received from the flow cytometer 402 may include flow cytometric event data. The processor 400 is configured to evaluate the data received from the flow cytometer 402, such as described above. For example, the processor 400 is configured to receive flow cytometric data associated with the illuminated first particle, and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively, from the detector. In addition, the processor 400 is configured to generate a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and based on the generated time interval, evaluate the obtained flow cytometric data for the presence of a coincident event by determining whether the first particle and the second particle are illuminated by the first and second light sources at the same time.

[0101] Processor 400 may be configured to provide a graphical display including bio-event data to display device 406. In some cases, processor 400 excludes flow cytometer data with coincident events so that it is not displayed on the graphical display (i.e., ignoring the affected flow cytometer data). In other cases, processor 400 assigns coincidence identifiers to the affected flow cytometer data. For example, the affected flow cytometer data may be marked as a specific color on the graphical display, or there may be a notification to draw the user's attention to the affected data. Processor 400 may be further configured to present the target area as a gate around the bio-event data group displayed by display device 406, for example, overlaid on a first figure. In some embodiments, the gate may be a logical combination of one or more graphical target areas drawn on a single parameter histogram or a bivariate graph. In some embodiments, the display may be used to display particle parameters or saturation detector data.

[0102] Processor 400 may also be configured to display the biological event data within the gate in a different manner from other events in the biological event data outside the gate on display device 406. For example, processor 400 may be configured to render the color of the biological event data contained within the gate different from the color of the biological event data outside the gate. Display device 406 may be implemented as a monitor, tablet computer, smart phone, or other electronic device configured to present a graphical interface.

[0103] The processor 400 may be configured to receive a door selection signal for identifying a door from a first input device. For example, the first input device may be implemented as a mouse 410. The mouse 410 may initiate a door selection signal to the processor 400 for identifying a door to be displayed on the display device 406 or manipulated by the display device 406 (e.g., by clicking on or in a desired door when a cursor is located on or in the desired door). In some embodiments, the first device may be implemented as a keyboard 408 or other device for providing input signals to the processor 400, such as a touch screen, a stylus, an optical detector, or a voice recognition system. Some input devices may include multiple input functions. In such embodiments, each input function may be considered an input device. For example, if Figure 4 As shown, the mouse 410 may include a right mouse button and a left mouse button, each of which may generate a trigger event.

[0104] A triggering event may cause processor 400 to change the manner in which data is displayed, the portion of data actually displayed on display device 406, and / or provide input for further processing (eg, selection of a target population for particle sorting).

[0105] In some embodiments, processor 400 can be configured to detect when mouse 410 initiates gate selection. Processor 400 can also be configured to automatically modify the plot visualization to facilitate the gating process. The modification can be based on a particular distribution of bio-event data received by processor 400. In some embodiments, processor 400 expands the first gate, thereby generating a second gate (e.g., as described above).

[0106] Processor 400 may be connected to storage device 404. Storage device 404 may be configured to receive and store biological event data from processor 400. Storage device 404 may also be configured to receive and store flow cytometry event data from processor 400. Storage device 404 may further be configured to allow processor 400 to retrieve biological event data, such as flow cytometry event data.

[0107] The display device 406 can be configured to receive display data from the processor 400. The display data can include a graph of biological event data and gates outlining portions of the graph. The display device 406 can be further configured to change the information presented based on input received from the processor 400 and input from the flow cytometer 402, the storage device 404, the keyboard 408, and / or the mouse 410.

[0108] In some embodiments, the processor 400 may generate a user interface to receive example events for classification. For example, the user interface may include a mechanism for receiving example events or example images. The example events or images or example gates may be provided before collecting event data for the sample, or may be provided based on an initial set of events for a portion of the sample.

[0109] Figure 5A is a schematic diagram of a particle sorter system 500 (e.g., flow cytometer 402) according to one embodiment described herein. In some embodiments, the particle sorter system 500 is a cell sorter system. Figure 5A As shown, a droplet formation transducer 502 (e.g., a piezoelectric oscillator) is coupled to a fluid conduit 501, which can be coupled to a nozzle 503, can include a nozzle 503, or can be a nozzle 503. Within the fluid conduit 501, a sheath fluid 504 hydrodynamically focuses a sample fluid 506 containing particles 509 into a moving fluid column 508 (e.g., a stream). Within the moving fluid column 508, the particles 509 (e.g., cells) are arranged in a single file to pass through a monitored area 511 (e.g., where the laser streams intersect) illuminated by a radiation source 512 (e.g., a laser). The vibration of the droplet formation transducer 502 causes the moving fluid column 508 to break into a plurality of droplets 510, some of which contain particles 509.

[0110] In operation, a detection station 514 (e.g., an event detector) identifies when a target particle (or target cell) passes through the monitored area 511. The detection station 514 feeds into a timing circuit 528, which in turn feeds into a flash charge circuit 530. At the droplet breakoff point, informed by a timed droplet delay (Δt), a flash charge can be applied to the moving fluid column 508 such that the target droplet is charged. The target droplet may include one or more particles or cells to be sorted. The charged droplets may then be sorted by activating a deflection plate (not shown) to deflect the droplet into a container (e.g., a collection tube or a multi-well or micro-porous sample plate), where a well or micro-well may be associated with a particular target droplet. As shown in FIG. Figure 5A As shown, the droplets may collect in a drain container 538 .

[0111] A detection system 516 (e.g., a droplet boundary detector) is used to automatically determine the phase of the droplet drive signal when a target particle passes through the monitored area 511. An exemplary droplet boundary detector is described in U.S. Patent No. 7,679,039, which is incorporated herein by reference in its entirety. The detection system 516 enables the instrument to accurately calculate the position of each detected particle in the droplet. The detection system 516 can feed an amplitude signal 520 and / or a phase 518 signal, which in turn feeds (via amplifier 522) an amplitude control circuit 526 and / or a frequency control circuit 524. The amplitude control circuit 526 and / or the frequency control circuit 524 in turn control the droplet formation sensor 502. The amplitude control circuit 526 and / or the frequency control circuit 524 can be included in the control system.

[0112] In some embodiments, the sorting electronics (e.g., detection system 516, detection station 514, and processor 540) can be coupled to a memory configured to store detected events and sorting decisions based on the events. The sorting decision can be included in the event data for the particle. In some embodiments, the detection system 516 and the detection station 514 can be implemented as a single detection unit or a communication coupled detection unit so that the event measurement can be collected by one of the detection system 516 or the detection station 514 and provided to the non-collecting element.

[0113] Figure 5B is a schematic diagram of a particle sorter system according to one embodiment presented herein. Figure 5B The particle sorter system 500 shown in FIG. 5 includes deflection plates 552 and 554. A charge can be applied via a stream of charging wires in the barbs. This produces a droplet stream 510 containing particles 509 for analysis. The particles can be illuminated with one or more light sources (e.g., lasers) to produce light scattering and fluorescence information. The particles are then sorted by a sorting electronics device or other detection system ( Figure 5BThe deflection plates 552 and 554 can be independently controlled to attract or repel charged droplets, thereby directing the droplets to a target collection container (e.g., one of 572, 574, 576, or 578). Figure 5B As shown, deflector plates 552 and 554 may be controlled to direct particles along first path 562 toward container 574 or along second path 568 toward container 578. If the particle is not a target (e.g., does not show scattering or illumination information within a specified sorting range), the deflector plates may allow the particle to continue to flow along flow path 564. Such uncharged droplets may, for example, be directed to a waste container via aspirator 570.

[0114] Sorting electronics can be included to initiate the collection of measurements, receive the fluorescent signal of the particle, and determine how to adjust the deflection plates to sort the particle. Figure 5B An example implementation of the embodiment shown in FIG. 1 includes a BD FACSAria commercially available from Becton, Dickinson and Company (Franklin Lakes, NJ). TM Serial flow cytometer.

[0115] Computer control system

[0116] Aspects of the present disclosure also include a computer control system, wherein the system includes one or more computers for full automation or partial automation. In some embodiments, the system includes a computer having a non-transitory computer-readable storage medium having a computer program stored thereon, wherein the computer program, when loaded onto the computer, includes instructions for receiving flow cytometer data associated with a first particle and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively. The target computer program also includes instructions for generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal, and based on the generated time interval, evaluating the flow cytometer data for the presence of a coincident event by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time.

[0117] The system may include a display and an operator input device. The operator input device may be a keyboard, a mouse, or the like. The processing module includes a processor that can access a memory on which instructions for executing the steps of the method of the subject are stored. The processing module may include an operating system, a graphical user interface (GUI) controller, a system memory, a memory storage device, an input-output controller, a cache, a data backup unit, and many other devices. The processor may be a commercially available processor or one of other processors that are currently available or to be launched. The processor executes an operating system, and the operating system interfaces with firmware and hardware in a well-known manner and helps the processor coordinate and execute the functions of various computer programs that can be written in various programming languages, such as Java, Perl, C++, Python, other high-level or low-level languages, and combinations thereof, as known in the art. The operating system typically collaborates with the processor to coordinate and execute the functions of other components of the computer. The operating system also provides scheduling, input-output control, file and data management, memory management, and communication control and related services, all of which are in accordance with known techniques. In some embodiments, the processor includes analog electronics that provide feedback control (e.g., negative feedback control).

[0118] The system memory may be any of a variety of known or future memory storage devices. Examples include any commonly used random access memory (RAM), magnetic media (e.g., resident hard disk or tape), optical media (e.g., read-write optical disks), flash memory devices, or other memory storage devices. The memory storage device may be any of a variety of known or future devices, including an optical disk drive, a tape drive, or a floppy disk drive. This type of memory storage device typically reads and / or writes to a program storage medium (e.g., an optical disk) from a program storage medium (not shown). Any of these program storage media, or other program storage media currently in use or that may be developed in the future, may be considered a computer program product. As will be appreciated, these program storage media typically store computer software programs and / or data. Computer software programs, also referred to as computer control logic, are typically stored in system memory and / or program storage devices used with the memory storage device.

[0119] In some embodiments, a computer program product is described, including a computer usable medium having control logic (computer software program, including program code) stored therein. The control logic, when executed by a computer processor, causes the processor to perform the functions described herein. In other embodiments, some functions are primarily implemented in hardware, such as using a hardware state machine. It is obvious to a person skilled in the relevant art to implement a hardware state machine to perform the functions described herein.

[0120] The memory may be any suitable device in which the processor can store and retrieve data, such as a magnetic, optical or solid-state storage device (including a magnetic or optical disk or tape or RAM, or any other suitable device, whether fixed or portable). The processor may include a general-purpose digital microprocessor that is appropriately programmed from a computer-readable medium carrying the necessary program code. The programming may be provided to the processor remotely via a communication channel, or previously saved in a computer program product (such as a memory or some other portable or fixed computer-readable storage medium) using any of these devices associated with the memory. For example, a magnetic or optical disk may carry the programming and may be read by a disk writer / reader. The system of the present invention also includes programming, such as in the form of a computer program product, for practicing the algorithms of the method described above. The programming according to the present invention may be recorded on a computer-readable medium, such as any medium that can be directly read and accessed by a computer. Such media include, but are not limited to: magnetic storage media, such as floppy disks, hard disk storage media, and tapes; optical storage media, such as CD-ROMs; electrical storage media, such as RAM and ROMs; portable flash drives; and hybrids of these categories, such as magnetic / optical storage media.

[0121] The processor may also access a communication channel to communicate with a user at a remote location. A remote location is one where the user is not directly engaging with the system, but rather is communicating input information to the input manager from an external device such as a computer connected to a wide area network ("WAN"), a telephone network, a satellite network, or any other suitable communication channel, including a mobile phone (i.e., a smartphone).

[0122] In some embodiments, a system according to the present disclosure may be configured to include a communication interface. In some embodiments, the communication interface includes a receiver and / or a transmitter for communicating with a network and / or another device. The communication interface may be configured for wired or wireless communication, including but not limited to radio frequency (RF) communication, for example, radio frequency identification (RFID), Zigbee communication protocol, Wi-Fi, infrared, wireless universal serial bus (USB), ultra-wideband (UWB), Communication protocols and cellular communications, such as Code Division Multiple Access (CDMA) or Global System for Mobile Communications (GSM).

[0123] In one embodiment, the communication interface is configured to include one or more communication ports, e.g., physical ports or interfaces such as a USB port, a USB-C port, an RS-232 port, or any other suitable electrical connection port to allow data communications between the subject system and other external devices (e.g., in a doctor's office or hospital environment) that are configured to conduct similar complementary data communications.

[0124] In one embodiment, the communication interface is configured as infrared communication, communications or any other suitable wireless communications protocol to enable the subject system to communicate with other devices such as computer terminals and / or networks, mobile phones with communications capabilities, personal digital assistants, or any other communications devices that a user may use in conjunction with the subject system.

[0125] In one embodiment, the communication interface is configured to provide a data transmission connection using Internet Protocol (IP) through a cellular network, a short message service (SMS), a wireless connection to a personal computer (PC) on a local area network (LAN) connected to the Internet, or a Wi-Fi connection to the Internet at a Wi-Fi hotspot.

[0126] In one embodiment, the subject system is configured to communicate wirelessly with a server device via a communication interface, for example, using a common standard such as 802.11 or RF protocol, or IrDA infrared protocol. The server device can be another portable device, such as a smart phone, a personal digital assistant (PDA), or a laptop; or a larger device, such as a desktop computer, an appliance, etc. In some embodiments, the server device has a display, such as a liquid crystal display (LCD), and an input device, such as a button, a keyboard, a mouse, or a touch screen.

[0127] In some embodiments, the communication interface is configured to automatically or semi-automatically communicate data stored in the subject system (eg, optional data storage unit) with a network or server device using one or more of the communication protocols and / or mechanisms described above.

[0128] The output controller may include controllers for various known display devices for presenting information to a user (whether a person or a machine, whether local or remote). If one of the display devices provides visual information, the information may generally be logically and / or physically organized as an array of image elements. A graphical user interface (GUI) controller may include various known or future software programs for providing a graphical input and output interface between the system and the user and for processing user input. The functional elements of the computer may communicate with each other via a system bus. In alternative embodiments, some of these communications may be implemented using a network or other types of remote communications. The output manager may also provide information generated by the processing module to a user at a remote location via the Internet, telephone, or satellite network according to known techniques. The presentation of data by the output manager may be implemented according to various known techniques. As some examples, the data may include SQL, HTML, or XML documents, emails or other files, or other forms of data. The data may include an Internet URL address so that a user can retrieve other SQL, HTML, XML, or other documents or data from a remote source. One or more platforms present in the system of the present subject may be any type of known computer platform or a type to be developed in the future, although they generally belong to a class of computers commonly referred to as servers. However, they may also be mainframe computers, workstations, or other computer types. They may be connected by any known or future type of cable or other communication system (including wireless systems), whether networked or otherwise. They may be co-located or physically separated. A variety of operating systems may be used on any computer platform, which may depend on the type and / or brand of computer platform selected. Suitable operating systems include XP, 7. 8. 10. Android TM 、SGI Oracle and others.

[0129] Figure 6 The general architecture of an example computing device 600 is shown in accordance with some embodiments. Figure 6The general architecture of the computing device 600 shown in includes an arrangement of computer hardware and software components. However, in order to provide an achievable disclosure, it is not necessary to show all of these generally conventional elements. As shown, the computing device 600 includes a processing unit 610, a network interface 620, a computer-readable medium drive 630, an input / output device interface 640, a display 650, and an input device 660, all of which can communicate with each other via a communication bus. The network interface 620 can provide a connection to one or more networks or computing systems. Therefore, the processing unit 610 can receive information and instructions from other computing systems or services via the network. The processing unit 610 can also communicate with the memory 670 and further provide output information to the optional display 650 via the input / output device interface 640. For example, analysis software (e.g., data analysis software or program, such as data analysis software) stored in a non-transitory memory of the analysis system as executable instructions ) can display flow cytometry event data to the user. The input / output device interface 640 can also accept input from an optional input device 660, such as a keyboard, mouse, digital pen, microphone, touch screen, gesture recognition system, voice recognition system, game controller, accelerometer, gyroscope or other input device.

[0130] Memory 670 may contain computer program instructions (in some embodiments, grouped into modules or components) that processing unit 610 executes to implement one or more embodiments. Memory 670 typically includes RAM, ROM, and / or other persistent, secondary, or non-transitory computer-readable media. Memory 670 may store an operating system 672 that provides computer program instructions for use by processing unit 610 in general management and operation of computing device 600. Data may be stored in data storage device 690. Memory 670 may also include computer program instructions and other information for implementing aspects of the present disclosure.

[0131] Practicality

[0132] The methods, systems, and computer systems of the subject matter can be used in a variety of applications in which it is necessary to analyze and optionally classify the particle components in a sample (e.g., a biological sample) in a flowing flow medium, and then store the sorted products, for example, for later use, such as therapeutic purposes. The present invention is particularly suitable for situations where flow cytometer data needs to be evaluated for the presence of coincident events. As the speed at which flow cytometers collect data continues to increase, the occurrence of coincident events becomes increasingly likely. Therefore, the present invention can be used in situations where it is necessary to increase the speed of analysis while maintaining data integrity. In addition, the methods, systems, and computer systems of the subject matter can be used in situations where it is necessary to include more colors in flow cytometer protocols. Because the trend of including more colors puts pressure on existing systems, such that the noise generated by such crosstalk can reduce the fidelity of the resulting data and may produce confusing artifacts, the present invention can be used to identify and mitigate the effects of crosstalk, thereby increasing the feasibility of protocols including more colors.

[0133] Embodiments of the present invention can be used in applications where cells need to be prepared from biological samples for research, laboratory testing, or for treatment. In some embodiments, the methods and devices of the present invention can help obtain single cells from a target fluid or tissue biological sample. For example, the methods and systems of the present subject matter help obtain cells from a fluid or tissue sample for use as a research or diagnostic sample for diseases such as cancer. Similarly, the methods and systems of the present subject matter can help obtain cells from a fluid or tissue sample for treatment. Compared to traditional flow cytometry systems, the methods and devices of the present disclosure can improve efficiency and reduce costs to separate and collect cells from biological samples (e.g., organs, tissues, tissue fragments, fluids).

[0134] Kits

[0135] Aspects of the present disclosure also include kits, wherein the kit includes storage media, such as magneto-optical disks, CD-ROMs, CD-Rs, magnetic tapes, non-volatile memory cards, ROMs, DVD-ROMs, Blu-ray discs, solid-state disks, and network attached storage (NAS). Any of these program storage media, or other program storage media currently in use or that may be developed later, may be included in the subject kit. In an embodiment, the program storage medium includes instructions for evaluating flow cytometer data for the presence of coincident events. In an embodiment, the instructions or a portion thereof included on the computer-readable medium provided in the subject kit may be implemented as a software component of the software for analyzing data. In these embodiments, a computer control system according to the present disclosure may be used as a software "plug-in" for an existing software package.

[0136] In addition to the above components, the kit may also include (in some embodiments) instructions, such as instructions for installing the plug-in into an existing software package. These instructions may be present in the kit in a variety of forms, one or more of which may be present in the kit. These instructions may be present in the form of printed information on a suitable medium or substrate, such as one or more sheets of printed information, packaging of the kit, package inserts, etc. Another form of these instructions is a computer-readable medium, such as a floppy disk, a compact disk (CD), a portable flash drive, and the like, in which the information is recorded. Another form of these instructions is a website address, which can be used to access information on a remote site via the Internet.

[0137] Notwithstanding the appended claims, the present disclosure is defined by the following terms:

[0138] 1. A method of evaluating flow cytometer data for the presence of coincident events, the method comprising:

[0139] take over:

[0140] flow cytometric data associated with the first particle, wherein the flow cytometric data is obtained from a detector after the first particle and the second particle in the flow are illuminated by the first light source and the second light source, respectively; and

[0141] a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively;

[0142] generating a time interval for the first and second particles based on a difference between the first trigger signal and the second trigger signal; and

[0143] Based on the generated time intervals, the flow cytometer data is evaluated for the presence of coincident events by determining whether the first particle and the second particle were illuminated by the first light source and the second light source at the same time.

[0144] 2. The method of clause 1, wherein evaluating the flow cytometer data comprises comparing the time interval to a measurement window associated with the second light source.

[0145] 3. The method according to clause 2, wherein the measurement window defines a time period during which irradiation of the second particle produces a coincidence event.

[0146] 4. A method according to clause 2 or 3, wherein evaluating the flow cytometer data includes determining based on the time interval whether the second particle falls within a measurement window of the second light source when the flow cytometer data associated with the first particle is obtained from the detector.

[0147] 5. The method of clause 1, wherein evaluating the flow cytometer data comprises comparing the time interval to a standard value.

[0148] 6. A method according to clause 5, wherein evaluating the flow cytometer data includes determining whether the time interval is below a standard value.

[0149] 7. A method according to any of the preceding clauses, further comprising assigning a coincidence identifier to flow cytometer data comprising coincident events.

[0150] 8. The method according to any one of clauses 1 to 6, further comprising ignoring flow cytometer data comprising coincident events.

[0151] 9. A method according to any of the preceding clauses, wherein the first trigger signal and the second trigger signal indicate a point in time at which the first particle and the second particle are detected in the flow stream, respectively.

[0152] 10. The method according to any of the preceding clauses, further comprising estimating a relative position of the first particle and the second particle within the flow stream based on the generated time interval.

[0153] 11. The method of any preceding clause, further comprising evaluating flow cytometric data associated with a plurality of different pairs of first particles and second particles within the particle sample.

[0154] 12. A method according to any preceding clause, wherein the first particle and the second particle are continuous particles within a flow stream.

[0155] 13. The method according to any one of clauses 1 to 11, wherein the first particles and the second particles are non-contiguous particles within the flow stream.

[0156] 14. A method according to any preceding clause, wherein the method comprises illuminating first and second particles in the flow stream with a first light source and a second light source, respectively.

[0157] 15. The method of clause 14, further comprising deactivating the second light source during the coincidence event.

[0158] 16. A method according to any of the preceding clauses, wherein the first light source and the second light source are selected from a plurality of light sources.

[0159] 17. The method of clause 16, wherein the number of light sources in the plurality of light sources is 2 to 10.

[0160] 18. The method of clause 16 or 17, wherein the plurality of light sources comprises one or more lasers.

[0161] 19. A method according to any of the preceding clauses, wherein the detector is selected from a plurality of detectors.

[0162] 20. The method of clause 19, wherein the number of detectors in the plurality of detectors is between 2 and 10.

[0163] 21. The method of clause 19 or 20, wherein the plurality of detectors comprises one or more detector arrays.

[0164] 22. A system comprising:

[0165] a flow cell configured to transport a particle sample in a flow stream;

[0166] a first light source and a second light source configured to illuminate first particles and second particles in the particle sample, respectively;

[0167] a detector configured to generate flow cytometric data associated with the first particle; and

[0168] Processor, configured as:

[0169] take over:

[0170] flow cytometer data from a detector associated with the illuminated first particle; and

[0171] a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively;

[0172] generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and

[0173] Based on the generated time intervals, the acquired flow cytometric data is evaluated for the presence of a coincident event by determining whether the first particle and the second particle were illuminated by the first and second light sources at the same time.

[0174] 23. The system of clause 22, wherein evaluating the flow cytometer data comprises comparing the time interval to a measurement window associated with the second light source.

[0175] 24. The system of clause 23, wherein the measurement window defines a time period during which irradiation of the second particle produces a coincident event.

[0176] 25. A system according to clause 23 or 24, wherein evaluating the flow cytometer data includes determining, based on the time interval, whether the second particle falls within a measurement window associated with the second light source when the flow cytometer data associated with the first particle is obtained from the detector.

[0177] 26. The system of clause 22, wherein evaluating the flow cytometer data comprises comparing the time interval to a standard value.

[0178] 27. The system of clause 26, wherein evaluating the flow cytometer data comprises determining whether the time interval is below a standard value.

[0179] 28. A system according to any of clauses 22 to 27, wherein the processor is configured to assign a coincidence identifier to flow cytometer data comprising coincidence events.

[0180] 29. A system according to any one of clauses 22 to 27, wherein the processor is configured to ignore flow cytometer data comprising coincident events.

[0181] 30. The system according to any of clauses 22 to 29, wherein the first trigger signal and the second trigger signal indicate a point in time at which the first particle and the second particle, respectively, are detected in the flow stream.

[0182] 31. The system according to any of clauses 22 to 30, wherein the processor is configured to estimate the relative position of the first particle and the second particle within the flow stream based on the generated time interval.

[0183] 32. The system of any of clauses 22 to 31, wherein the processor is configured to evaluate flow cytometric data associated with a plurality of different pairs of first particles and second particles within the particle sample.

[0184] 33. The system of any of clauses 22 to 32, wherein the processor is configured to deactivate the second light source during the coincidence event.

[0185] 34. The system according to any of clauses 22 to 33, wherein the first light source and the second light source are selected from a plurality of light sources.

[0186] 35. The system of clause 34, wherein the number of light sources in the plurality of light sources is between 2 and 10.

[0187] 36. A system according to clause 34 or 35, wherein the plurality of light sources comprises one or more lasers.

[0188] 37. The system of any one of clauses 22 to 36, wherein the detector is selected from a plurality of detectors.

[0189] 38. A system according to clause 37, wherein the number of detectors in the plurality of detectors is between 2 and 10.

[0190] 39. The system of clause 37 or 38, wherein the plurality of detectors comprises one or more detector arrays.

[0191] 40. A system according to any one of clauses 22 to 39, wherein the system is a flow cytometer.

[0192] 41. A system according to any one of clauses 22 to 40, further comprising a display configured to output flow cytometer data evaluated by the processor.

[0193] 42. A non-transitory computer readable storage medium comprising instructions stored thereon for evaluating flow cytometer data for the presence of coincident events by a method comprising:

[0194] take over:

[0195] flow cytometric data associated with the first particle, wherein the flow cytometric data is obtained from a detector after the first particle and the second particle in the flow are illuminated by the first light source and the second light source, respectively; and

[0196] a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively;

[0197] generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and

[0198] Based on the generated time intervals, the flow cytometer data is evaluated for the presence of coincident events by determining whether the first particle and the second particle were illuminated by the first light source and the second light source at the same time.

[0199] 43. The non-transitory computer-readable storage medium of clause 42, wherein evaluating the flow cytometer data comprises comparing the time interval to a measurement window associated with the second light source.

[0200] 44. The non-transitory computer-readable storage medium of clause 43, wherein the measurement window defines a time period during which irradiation of the second particle produces a coincident event.

[0201] 45. A non-transitory computer-readable storage medium according to clause 43 or 44, wherein evaluating the flow cytometer data includes determining, based on the time interval, whether the second particle falls within a measurement window associated with the second light source when the flow cytometer data associated with the first particle is obtained from the detector.

[0202] 46. ​​The non-transitory computer-readable storage medium of clause 42, wherein evaluating the flow cytometer data comprises comparing the time interval to a standard value.

[0203] 47. The non-transitory computer-readable storage medium of clause 46, wherein evaluating the flow cytometer data comprises determining whether the time interval is below a standard value.

[0204] 48. The non-transitory computer-readable storage medium of any of clauses 42 to 47, wherein the method further comprises assigning a coincidence identifier to flow cytometer data comprising coincident events.

[0205] 49. The non-transitory computer-readable storage medium of any one of clauses 42 to 47, wherein the method further comprises ignoring flow cytometer data comprising coincident events.

[0206] 50. The non-transitory computer-readable storage medium of any of clauses 42 to 49, wherein the first trigger signal and the second trigger signal indicate a point in time at which the first particle and the second particle, respectively, are detected in the flow stream.

[0207] 51. The non-transitory computer-readable storage medium of any of clauses 42 to 50, wherein the method further comprises estimating a relative position of the first particle and the second particle within the flow stream based on the generated time interval.

[0208] 52. The non-transitory computer-readable storage medium of any of clauses 42 to 51, wherein the method further comprises evaluating flow cytometer data associated with a plurality of different pairs of first particles and second particles within the particle sample.

[0209] 53. The non-transitory computer-readable storage medium of any of clauses 42 to 52, wherein the method further comprises deactivating the second light source during the coincidence event.

[0210] 54. The non-transitory computer-readable storage medium of any of clauses 42 to 53, wherein the first light source and the second light source are selected from a plurality of light sources.

[0211] 55. The non-transitory computer-readable storage medium of clause 54, wherein the number of light sources in the plurality of light sources is between 2 and 10.

[0212] 56. The non-transitory computer-readable storage medium of clause 54 or 55, wherein the plurality of light sources comprises one or more lasers.

[0213] 57. The non-transitory computer-readable storage medium of any of clauses 42 to 56, wherein the detector is selected from a plurality of detectors.

[0214] 58. The non-transitory computer-readable storage medium of clause 57, wherein the number of detectors in the plurality of detectors is between 2 and 10.

[0215] 59. The non-transitory computer-readable storage medium of clause 57 or 58, wherein the plurality of detectors comprises one or more detector arrays.

[0216] 60. A method of evaluating flow cytometer data, the method comprising:

[0217] (a) introducing a particle sample into a system, the system comprising:

[0218] a flow cell configured to transport a particle sample in a flow stream;

[0219] a first light source and a second light source configured to illuminate first particles and second particles in the particle sample, respectively;

[0220] a detector configured to generate flow cytometric data associated with the first particle; and

[0221] Processor, configured as:

[0222] take over:

[0223] flow cytometer data from a detector associated with the illuminated first particle; and

[0224] a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively;

[0225] generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and

[0226] evaluating the acquired flow cytometer data for the presence of a coincident event by determining whether the first particle and the second particle were illuminated by the first light source and the second light source at the same time based on the generated time interval; and

[0227] (b) Receive evaluated flow cytometer data from a processor.

[0228] 61. The method of clause 60, wherein evaluating the flow cytometer data comprises comparing the time interval to a measurement window associated with the second light source.

[0229] 62. A method according to clause 61, wherein the measurement window defines a time period during which irradiation of the second particle produces a coincident event.

[0230] 63. A method according to clause 61 or 62, wherein evaluating the flow cytometer data includes determining, based on the time interval, whether the second particle falls within a measurement window associated with the second light source when the flow cytometer data associated with the first particle is obtained from the detector.

[0231] 64. A method according to clause 60, wherein evaluating the flow cytometer data includes comparing the time interval to a standard value.

[0232] 65. A method according to clause 64, wherein evaluating the flow cytometer data includes determining whether the time interval is below a standard value.

[0233] 66. A method according to any of clauses 60 to 65, wherein the processor is configured to assign a coincidence identifier to flow cytometer data comprising coincidence events.

[0234] 67. A method according to any one of clauses 60 to 65, wherein the processor is configured to ignore flow cytometer data comprising coincident events.

[0235] 68. A method according to any of clauses 60 to 67, wherein the first trigger signal and the second trigger signal indicate a point in time at which the first particle and the second particle, respectively, are detected in the flow stream.

[0236] 69. A method according to any of clauses 60 to 68, wherein the processor is configured to estimate the relative position of the first particle and the second particle within the flow stream based on the generated time interval.

[0237] 70. A method according to any of clauses 60 to 69, wherein the processor is configured to evaluate flow cytometric data associated with a plurality of different pairs of first particles and second particles within the particle sample.

[0238] 71. The method of any of clauses 60 to 70, wherein the first particle and the second particle are continuous particles within the flow stream.

[0239] 72. The method of any of clauses 60 to 70, wherein the first particle and the second particle are non-contiguous particles within the flow stream.

[0240] 73. The method of any one of clauses 60 to 72, wherein the first light source and the second light source are selected from a plurality of light sources.

[0241] 74. The method of clause 73, wherein the number of light sources in the plurality of light sources is between 2 and 10.

[0242] 75. A method according to clause 73 or 74, wherein the plurality of light sources comprises one or more lasers.

[0243] 76. The method according to any one of clauses 60 to 75, wherein the detector is selected from a plurality of detectors.

[0244] 77. A method according to clause 76, wherein the number of detectors in the plurality of detectors is between 2 and 10.

[0245] 78. A method according to clause 76 or 77, wherein the plurality of detectors comprises one or more detector arrays.

[0246] 79. A method according to any of clauses 60 to 78, wherein the processor is configured to deactivate the second light source during the coincidence event.

[0247] 80. The method according to any one of clauses 60 to 79, wherein the system is a flow cytometer.

[0248] 81. The method of any one of clauses 60 to 80, wherein the system further comprises a display configured to output the flow cytometer data evaluated by the processor.

[0249] Although the foregoing invention has been described in some detail through illustration and example for ease of understanding, it is apparent to those skilled in the art that, based on the teachings of the present invention, some changes and modifications may be easily made thereto without departing from the spirit or scope of the appended claims.

[0250] Therefore, the above content only illustrates the principles of the present invention. It is understood that those skilled in the art will be able to design various devices, which, although not explicitly described or shown here, embody the principles of the present invention and are included in its spirit and scope. In addition, all examples and conditional language described herein are mainly intended to help readers understand the principles of the present invention and the concepts contributed by the inventors to promote technological progress, and should be interpreted as not being limited to these specifically described examples and conditions. In addition, all statements described herein, including the principles, aspects and embodiments of the present invention and their specific examples, are intended to cover their structural and functional equivalents. In addition, such equivalents are intended to include currently known equivalents and equivalents developed in the future, that is, any element developed to perform the same function regardless of the structure. In addition, anything disclosed herein is not intended to be dedicated to the public, regardless of whether such disclosure is clearly recorded in the claims.

[0251] Therefore, the scope of the present disclosure is not intended to be limited to the exemplary embodiments shown and described in the present disclosure. On the contrary, the scope and spirit of the present invention are embodied in the appended claims. In the claims, 35 U.S.C. § 112(f) or 35 U.S.C. § 112(6) expressly defines that only when the exact phrase "a method for..." or the exact phrase "a step for..." is cited at the beginning of such limitation in the claim, the limitation in the claim is cited at the beginning; if the limitation in the claim does not use such exact phrases, 35 U.S.C. § 112(f) or 35 U.S.C. § 112(6) is not cited.

Claims

1. A method of evaluating flow cytometer data for the presence of coincident events, the method comprising: take over: flow cytometric data associated with the first particle, wherein the flow cytometric data is obtained from a detector after the first particle and the second particle in the flow stream are illuminated by the first light source and the second light source, respectively; and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively; generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and Based on the generated time intervals, the flow cytometer data is evaluated for the presence of coincident events by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time.

2. The method according to claim 1, wherein: Evaluating the flow cytometer data includes comparing the time interval to a measurement window associated with the second light source.

3. The method according to claim 2, wherein: The measurement window defines the time period during which illumination of the second particle produces a coincident event.

4. The method according to claim 2 or 3, wherein: Evaluating the flow cytometer data includes determining, based on the time interval, whether the second particle falls within a measurement window of the second light source while the flow cytometer data associated with the first particle is being obtained from the detector.

5. The method according to claim 1, wherein: Evaluation of flow cytometry data involves comparing the time intervals to standard values.

6. The method according to claim 5, wherein: Evaluating the flow cytometer data includes determining whether the time interval is below the standard value.

7. The method of any of the preceding claims, further comprising assigning a coincidence identifier to flow cytometer data comprising coincident events.

8. The method of any one of claims 1 to 6, further comprising disregarding flow cytometer data comprising coincident events.

9. A method according to any one of the preceding claims, wherein: The first trigger signal and the second trigger signal indicate a point in time at which a first particle and a second particle are detected in the flow stream, respectively.

10. The method of any of the preceding claims, further comprising estimating the relative positions of the first and second particles within the flow stream based on the generated time intervals.

11. The method of any of the preceding claims, further comprising evaluating flow cytometric data associated with a plurality of different pairs of first particles and second particles within the particle sample.

12. A method according to any one of the preceding claims, wherein: The first particle and the second particle are continuous particles within the flow stream.

13. The method according to any one of claims 1 to 11, wherein: The first particle and the second particle are discrete particles within the flow stream.

14. A system comprising: a flow cell configured to transport a particle sample in a flow stream; a first light source and a second light source configured to illuminate first particles and second particles in the particle sample, respectively; a detector configured to generate flow cytometric data associated with the first particle; as well as Processor, configured as: take over: flow cytometric data from the detector associated with the illuminated first particle; and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively; generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and Based on the generated time interval, the acquired flow cytometric data is evaluated for the presence of a coincident event by determining whether the first particle and the second particle are illuminated by the first light source and the second light source at the same time.

15. A method for evaluating flow cytometer data, the method comprising: (a) introducing a particle sample into a system, the system comprising: a flow cell configured to transport a particle sample in a flow stream; a first light source and a second light source configured to illuminate first particles and second particles in the particle sample, respectively; a detector configured to generate flow cytometric data associated with the first particle; and Processor, configured as: take over: flow cytometer data from the detector associated with the illuminated first particle; and a first trigger signal and a second trigger signal associated with the first particle and the second particle, respectively; generating a time interval for the first particle and the second particle based on a difference between the first trigger signal and the second trigger signal; and evaluating the acquired flow cytometer data for the presence of a coincident event by determining whether the first particle and the second particle were illuminated by the first light source and the second light source simultaneously based on the generated time interval; and (b) receiving the evaluated flow cytometer data from the processor.

Citation Information

Patent Citations

  • Parallel flow cytometer using radiofrequency multiplexing

    US10451538B2

  • Multi-photon counting for high sensitivity flow cytometer systems and methods for using the same

    US10578542B2

  • Light detection systems and methods for using thereof

    US10585031B2

  • Droplet deflectors and methods for using the same

    US10605713B2

  • Biexponential transformation for particle sorters

    US10613017B2